| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| endonuclease IV | 22 | 0 | 0 | 22 |
| thioredoxin reductase | 111 | 0 | 0 | 111 |
| aldehyde dehydrogenase 1 family, member A1 | 108 | 0 | 0 | 108 |
| euchromatic histone-lysine N-methyltransferase 2 | 192 | 0 | 0 | 192 |
| Bloom syndrome protein isoform 1 | 59 | 0 | 0 | 59 |
| lamin isoform A-delta10 | 171 | 0 | 0 | 171 |
| Muscarinic acetylcholine receptor M2 | 0 | 68 | 10 | 83 |
| Muscarinic acetylcholine receptor M4 | 0 | 62 | 8 | 74 |
| Muscarinic acetylcholine receptor M5 | 0 | 60 | 8 | 72 |
| Muscarinic acetylcholine receptor M1 | 0 | 69 | 12 | 87 |
| Muscarinic acetylcholine receptor M3 | 0 | 63 | 10 | 77 |
| Muscarinic acetylcholine receptor | 0 | 11 | 1 | 12 |
| IDH1 | 46 | 0 | 0 | 46 |
| chromobox protein homolog 1 | 110 | 0 | 0 | 110 |
| geminin | 155 | 0 | 0 | 155 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 50 | 0 | 0 | 50 |
| 5-hydroxytryptamine receptor 3E | 0 | 5 | 1 | 6 |
| acetylcholinesterase | 66 | 0 | 0 | 66 |
| TDP1 protein | 168 | 0 | 0 | 168 |
| cytochrome P450 2D6 | 106 | 0 | 0 | 106 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 71 | 0 | 0 | 71 |
| cytochrome P450 2D6 isoform 1 | 62 | 0 | 0 | 62 |
| cellular tumor antigen p53 isoform a | 33 | 0 | 0 | 33 |
| cytochrome P450 2C19 precursor | 47 | 0 | 0 | 47 |
| cytochrome P450 2C9 precursor | 46 | 0 | 0 | 46 |
| thyroid hormone receptor beta isoform a | 40 | 0 | 0 | 40 |
| thyroid hormone receptor beta isoform 2 | 131 | 0 | 0 | 131 |
| huntingtin isoform 2 | 22 | 0 | 0 | 22 |
| peripheral myelin protein 22 | 97 | 0 | 0 | 97 |
| cytochrome P450 3A4 isoform 1 | 94 | 0 | 0 | 94 |
| muscarinic acetylcholine receptor M1 | 71 | 0 | 0 | 71 |
| Gamma-aminobutyric acid receptor subunit pi | 94 | 15 | 8 | 117 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 41 | 0 | 0 | 41 |
| ATP-binding cassette sub-family C member 3 | 0 | 126 | 0 | 126 |
| Multidrug resistance-associated protein 4 | 0 | 127 | 0 | 132 |
| 5-hydroxytryptamine receptor 3B | 0 | 5 | 1 | 6 |
| Bile salt export pump | 0 | 209 | 0 | 209 |
| Beta-1 adrenergic receptor | 0 | 36 | 19 | 55 |
| 5-hydroxytryptamine receptor 1A | 0 | 19 | 5 | 24 |
| 5-hydroxytryptamine receptor 2C | 0 | 22 | 3 | 26 |
| D(2) dopamine receptor | 0 | 61 | 2 | 65 |
| 5-hydroxytryptamine receptor 2A | 0 | 26 | 4 | 30 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 94 | 15 | 8 | 117 |
| Alpha-1B adrenergic receptor | 0 | 56 | 7 | 63 |
| Gamma-aminobutyric acid receptor subunit delta | 94 | 15 | 8 | 117 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 94 | 15 | 10 | 119 |
| D | 0 | 15 | 0 | 15 |
| 5-hydroxytryptamine receptor 1A | 0 | 81 | 10 | 92 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 94 | 15 | 8 | 117 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 94 | 15 | 8 | 117 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 94 | 16 | 8 | 118 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 94 | 15 | 8 | 117 |
| Alpha-1D adrenergic receptor | 0 | 34 | 7 | 42 |
| 5-hydroxytryptamine receptor 2A | 0 | 79 | 3 | 82 |
| 5-hydroxytryptamine receptor 2C | 0 | 80 | 2 | 82 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 94 | 15 | 8 | 117 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 94 | 15 | 8 | 117 |
| 5-hydroxytryptamine receptor 1B | 0 | 59 | 3 | 62 |
| 5-hydroxytryptamine receptor 1D | 0 | 14 | 3 | 17 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 94 | 15 | 8 | 117 |
| 5-hydroxytryptamine receptor 1F | 0 | 14 | 3 | 17 |
| 5-hydroxytryptamine receptor 5A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 20 | 3 | 23 |
| Sodium-dependent serotonin transporter | 0 | 48 | 1 | 49 |
| 5-hydroxytryptamine receptor 7 | 0 | 12 | 2 | 14 |
| 5-hydroxytryptamine receptor 7 | 0 | 11 | 1 | 12 |
| Alpha-1B adrenergic receptor | 0 | 15 | 8 | 27 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 17 | 3 | 23 |
| 5-hydroxytryptamine receptor 2B | 0 | 82 | 2 | 84 |
| Alpha-1A adrenergic receptor | 0 | 60 | 8 | 68 |
| 5-hydroxytryptamine receptor 3A | 0 | 6 | 1 | 7 |
| Histamine H2 receptor | 70 | 6 | 3 | 85 |
| 5-hydroxytryptamine receptor 6 | 0 | 51 | 1 | 53 |
| Beta-2 adrenergic receptor | 0 | 4 | 1 | 5 |
| D(2) dopamine receptor | 0 | 22 | 3 | 25 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 94 | 18 | 10 | 122 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 94 | 15 | 8 | 117 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 94 | 15 | 10 | 119 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 16 | 3 | 22 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 17 | 3 | 23 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 16 | 3 | 23 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 16 | 3 | 22 |
| 5-hydroxytryptamine receptor 3D | 0 | 5 | 1 | 6 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 16 | 3 | 22 |
| 5-hydroxytryptamine receptor 3C | 0 | 5 | 1 | 6 |
| GABA theta subunit | 94 | 15 | 8 | 117 |
| Canalicular multispecific organic anion transporter 1 | 0 | 122 | 0 | 123 |
| Gamma-aminobutyric acid receptor subunit epsilon | 94 | 15 | 8 | 117 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 16 | 3 | 22 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 86 | 0 | 0 | 86 |
| Chain A, Cruzipain | 33 | 0 | 0 | 33 |
| regulator of G-protein signaling 4 | 88 | 0 | 0 | 88 |
| Platelet-activating factor receptor | 0 | 6 | 0 | 7 |
| Inositol monophosphatase 1 | 38 | 0 | 0 | 38 |
| Chain A, High-affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Chain A, Phosphodiesterase 9A | 0 | 1 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 23 | 0 | 0 | 23 |
| Chain A, Class I phosphodiesterase PDEB1 | 0 | 1 | 0 | 1 |
| Chain A, High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 1 | 0 | 1 |
| Chain A, cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase catalytic domain, Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha chimera | 0 | 1 | 0 | 1 |
| Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase catalytic domain, Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha chimera | 0 | 1 | 0 | 1 |
| Chain A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 1 | 0 | 1 |
| Chain A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 1 | 0 | 1 |
| glp-1 receptor, partial | 54 | 0 | 0 | 54 |
| thyroid stimulating hormone receptor | 91 | 0 | 0 | 91 |
| estrogen-related nuclear receptor alpha | 163 | 0 | 0 | 163 |
| Phosphodiesterase | 0 | 4 | 0 | 4 |
| mitogen-activated protein kinase 1 | 57 | 0 | 0 | 57 |
| histone acetyltransferase KAT2A isoform 1 | 64 | 0 | 0 | 64 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 12 | 0 | 12 |
| Monocarboxylate transporter 4 | 0 | 2 | 0 | 2 |
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 9 | 0 | 9 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 14 | 0 | 15 |
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | 0 | 2 | 0 | 2 |
| Renin | 0 | 6 | 0 | 6 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 5 | 0 | 5 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 8 | 0 | 10 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 8 | 0 | 10 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 8 | 0 | 11 |
| Adenosine receptor A1 | 0 | 26 | 4 | 35 |
| Adenosine receptor A3 | 0 | 9 | 0 | 9 |
| Adenosine receptor A2a | 0 | 17 | 10 | 33 |
| Adenosine receptor A2b | 0 | 11 | 3 | 19 |
| Adenosine receptor A2b | 0 | 12 | 3 | 20 |
| Adenosine receptor A1 | 0 | 17 | 9 | 33 |
| Adenosine receptor A2a | 0 | 24 | 4 | 37 |
| Sodium-dependent serotonin transporter | 0 | 21 | 1 | 23 |
| Adenosine receptor A2a | 0 | 4 | 0 | 4 |
| Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 8 | 0 | 10 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 8 | 0 | 9 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 4 | 0 | 4 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 11 | 0 | 12 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 18 | 1 | 19 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 18 | 1 | 20 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 13 | 0 | 14 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 27 | 0 | 28 |
| High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A | 0 | 5 | 0 | 5 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 9 | 0 | 10 |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 13 | 0 | 14 |
| Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 2 | 0 | 2 |
| Phosphodiesterase | 0 | 1 | 0 | 1 |
| Phosphodiesterase | 0 | 2 | 0 | 2 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 7B | 0 | 7 | 0 | 7 |
| ATAD5 protein, partial | 73 | 0 | 0 | 73 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 45 | 0 | 0 | 45 |
| 67.9K protein | 34 | 0 | 0 | 34 |
| peripheral myelin protein 22 isoform 1 | 43 | 0 | 0 | 43 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 38 | 0 | 0 | 39 |
| DNA polymerase iota isoform a (long) | 59 | 0 | 0 | 59 |
| nuclear receptor ROR-gamma isoform 1 | 62 | 0 | 0 | 62 |
| Adenosine receptor A3 | 0 | 35 | 4 | 40 |
| Adenosine receptor A1 | 0 | 4 | 0 | 4 |
| Vasopressin V2 receptor | 0 | 0 | 0 | 2 |
| Mu-type opioid receptor | 0 | 32 | 9 | 43 |
| Adenosine receptor A1 | 0 | 4 | 2 | 6 |
| Adenylate cyclase type 5 | 0 | 2 | 0 | 3 |
| Adenylate cyclase type 1 | 0 | 1 | 1 | 4 |
| Sigma non-opioid intracellular receptor 1 | 0 | 13 | 2 | 15 |
| Thyroid hormone receptor beta | 0 | 4 | 0 | 4 |
| RAR-related orphan receptor gamma | 141 | 0 | 0 | 141 |
| GLI family zinc finger 3 | 140 | 0 | 0 | 140 |
| nuclear receptor subfamily 1, group I, member 3 | 114 | 0 | 0 | 114 |
| progesterone receptor | 85 | 0 | 0 | 85 |
| retinoic acid nuclear receptor alpha variant 1 | 129 | 0 | 0 | 129 |
| pregnane X nuclear receptor | 126 | 0 | 0 | 126 |
| estrogen nuclear receptor alpha | 226 | 0 | 0 | 226 |
| Guanine nucleotide-binding protein G | 16 | 0 | 0 | 16 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 29 | 0 | 0 | 29 |
| Chain A, HADH2 protein | 48 | 0 | 0 | 48 |
| Chain B, HADH2 protein | 48 | 0 | 0 | 48 |
| phosphopantetheinyl transferase | 61 | 0 | 0 | 61 |
| GLS protein | 99 | 0 | 0 | 99 |
| 5-hydroxytryptamine receptor 3A | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 1D | 0 | 6 | 0 | 8 |
| 5-hydroxytryptamine receptor 1E | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 3A | 0 | 12 | 2 | 14 |
| 5-hydroxytryptamine receptor 5A | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 3B | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 3B | 0 | 12 | 2 | 14 |
| Luciferase | 62 | 0 | 0 | 62 |
| AR protein | 196 | 0 | 0 | 196 |
| estrogen receptor 2 (ER beta) | 72 | 0 | 0 | 72 |
| retinoid X nuclear receptor alpha | 107 | 0 | 0 | 107 |
| peroxisome proliferator-activated receptor delta | 87 | 0 | 0 | 87 |
| aryl hydrocarbon receptor | 72 | 0 | 0 | 72 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 89 | 0 | 0 | 89 |
| Histone H2A.x | 60 | 0 | 0 | 60 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 134 | 0 | 0 | 134 |
| DNA repair and recombination protein RadA | 0 | 0 | 1 | 1 |
| Voltage-dependent calcium channel gamma-2 subunit | 67 | 0 | 0 | 67 |
| Cellular tumor antigen p53 | 122 | 0 | 0 | 122 |
| Cytochrome P450 1A2 | 0 | 17 | 0 | 19 |
| Cytochrome P450 2A6 | 0 | 11 | 3 | 14 |
| Sulfotransferase 1A1 | 0 | 0 | 0 | 3 |
| Glutamate receptor 2 | 68 | 1 | 2 | 73 |
| Cytochrome P450 2A5 | 0 | 5 | 0 | 5 |
| Sulfotransferase 1E1 | 0 | 0 | 0 | 1 |
| Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
| Sulfotransferase 2A1 | 0 | 0 | 0 | 1 |
| pregnane X receptor | 17 | 0 | 0 | 17 |
| glucocorticoid receptor [Homo sapiens] | 141 | 0 | 0 | 141 |
| peroxisome proliferator activated receptor gamma | 94 | 0 | 0 | 94 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 96 | 0 | 0 | 96 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 52 | 0 | 0 | 52 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 21 | 0 | 0 | 21 |
| histone deacetylase 9 isoform 3 | 18 | 0 | 0 | 18 |
| survival motor neuron protein isoform d | 53 | 0 | 0 | 53 |
| Integrin beta-3 | 21 | 3 | 0 | 24 |
| Integrin alpha-IIb | 21 | 1 | 0 | 22 |
| Nuclear receptor ROR-gamma | 34 | 1 | 1 | 36 |
| TAR DNA-binding protein 43 | 36 | 0 | 0 | 36 |
| ATPase family AAA domain-containing protein 5 | 58 | 0 | 0 | 58 |
| Ataxin-2 | 94 | 0 | 0 | 94 |
| Chain A, 2-oxoglutarate Oxygenase | 66 | 0 | 0 | 66 |
| Chain A, Ferritin light chain | 37 | 0 | 0 | 37 |
| Poly [ADP-ribose] polymerase 2 | 0 | 1 | 0 | 1 |
| Poly [ADP-ribose] polymerase 1 | 0 | 2 | 0 | 2 |
| Poly [ADP-ribose] polymerase 1 | 0 | 1 | 0 | 1 |
| Transporter | 0 | 13 | 1 | 15 |
| ATP-dependent phosphofructokinase | 86 | 0 | 0 | 86 |
| Gamma-aminobutyric acid receptor subunit rho-3 | 0 | 0 | 1 | 2 |
| NFKB1 protein, partial | 37 | 0 | 0 | 37 |
| Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 4 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit rho-1 | 0 | 0 | 4 | 5 |
| Gamma-aminobutyric acid receptor subunit rho-2 | 0 | 0 | 2 | 3 |
| 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 3 | 0 | 3 |
| Cholinesterase | 0 | 11 | 0 | 11 |
| Acetylcholinesterase | 0 | 26 | 1 | 27 |
| Genome polyprotein | 0 | 2 | 1 | 3 |
| USP1 protein, partial | 85 | 0 | 0 | 85 |
| transcriptional regulator ERG isoform 3 | 13 | 0 | 0 | 13 |
| Polyphenol oxidase 2 | 0 | 9 | 1 | 12 |
| Thiopurine S-methyltransferase | 0 | 2 | 0 | 2 |
| Succinate-semialdehyde dehydrogenase, mitochondrial | 0 | 2 | 0 | 2 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 3 | 0 | 4 |
| Cytochrome P450 1B1 | 0 | 3 | 0 | 3 |
| Dihydropteroate synthase | 0 | 0 | 1 | 1 |
| Chain A, Toluene-4-monooxygenase system protein A | 0 | 1 | 0 | 1 |
| Trypsin-1 | 0 | 2 | 0 | 2 |
| D(1A) dopamine receptor | 55 | 0 | 0 | 55 |
| serine/threonine-protein kinase mTOR isoform 1 | 32 | 0 | 0 | 32 |
| lethal factor (plasmid) | 47 | 0 | 0 | 47 |
| ras-related protein Rab-9A | 23 | 0 | 0 | 23 |
| D(1A) dopamine receptor | 17 | 2 | 0 | 19 |
| 5-hydroxytryptamine receptor 6 | 0 | 5 | 2 | 7 |
| 5-hydroxytryptamine receptor 5A | 0 | 5 | 2 | 7 |
| 5-hydroxytryptamine receptor 5B | 0 | 5 | 2 | 7 |
| 5-hydroxytryptamine receptor 4 | 0 | 6 | 3 | 11 |
| hypoxia-inducible factor 1 alpha subunit | 45 | 0 | 0 | 45 |
| activating transcription factor 6 | 64 | 0 | 0 | 64 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 50 | 0 | 0 | 50 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 80 | 0 | 0 | 80 |
| heat shock protein beta-1 | 47 | 0 | 0 | 47 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 4 | 0 | 0 | 4 |
| Microtubule-associated protein tau | 81 | 0 | 0 | 81 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 14 | 1 | 17 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 21 | 0 | 0 | 21 |
| Mcl-1 | 0 | 1 | 0 | 1 |
| Myeloid cell leukemia sequence 1 (BCL2-related) | 0 | 1 | 0 | 1 |
| thioredoxin glutathione reductase | 27 | 0 | 0 | 27 |
| envelope glycoprotein | 0 | 1 | 0 | 1 |
| core protein, partial | 0 | 1 | 0 | 1 |
| bromodomain adjacent to zinc finger domain 2B | 36 | 0 | 0 | 36 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 14 | 0 | 0 | 14 |
| glyceraldehyde-3-phosphate dehydrogenase isoform 1 | 1 | 1 | 0 | 2 |
| DNA polymerase beta | 20 | 0 | 0 | 20 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 14 | 0 | 0 | 14 |
| eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 2 | 0 | 2 |
| eukaryotic translation initiation factor 4E isoform 1 | 0 | 2 | 0 | 2 |
| DNA polymerase kappa isoform 1 | 48 | 0 | 0 | 48 |
| Vif | 0 | 1 | 0 | 1 |
| Tat | 0 | 1 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 5 | 1 | 0 | 6 |
| dual specificity protein phosphatase 6 | 0 | 1 | 0 | 1 |
| POsterior Segregation | 0 | 0 | 2 | 3 |
| tyrosine-protein phosphatase non-receptor type 7 isoform 2 | 0 | 2 | 0 | 2 |
| bcl-2-like protein 1 isoform Bcl-X(L) | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 27 | 6 | 40 |
| Muscarinic acetylcholine receptor M3 | 0 | 23 | 5 | 33 |
| Muscarinic acetylcholine receptor M4 | 0 | 24 | 3 | 32 |
| Muscarinic acetylcholine receptor M5 | 0 | 25 | 3 | 33 |
| Muscarinic acetylcholine receptor M2 | 0 | 27 | 5 | 39 |
| Caspase-1 | 1 | 7 | 0 | 9 |
| Zinc finger protein mex-5 | 0 | 0 | 2 | 3 |
| Thromboxane A2 receptor | 0 | 5 | 2 | 8 |
| Thromboxane-A synthase | 0 | 11 | 0 | 11 |
| Thromboxane-A synthase | 0 | 3 | 0 | 3 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 4 | 0 | 10 |
| Thrombopoietin | 27 | 0 | 0 | 27 |
| glucocerebrosidase | 29 | 0 | 0 | 29 |
| arylsulfatase A | 80 | 0 | 0 | 80 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 14 | 0 | 22 |
| Nrf2 | 1 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 34 | 0 | 0 | 34 |
| Smad3 | 33 | 0 | 0 | 33 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 122 | 0 | 0 | 122 |
| G | 71 | 0 | 0 | 71 |
| hexokinase-4 isoform 1 | 10 | 0 | 0 | 10 |
| vitamin D3 receptor isoform VDRA | 64 | 0 | 0 | 64 |
| glucokinase regulatory protein | 10 | 0 | 0 | 10 |
| flap endonuclease 1 | 39 | 0 | 0 | 39 |
| serine/threonine-protein kinase PLK1 | 12 | 0 | 0 | 12 |
| DNA polymerase eta isoform 1 | 13 | 0 | 0 | 13 |
| M-phase phosphoprotein 8 | 38 | 0 | 0 | 38 |
| neuropeptide S receptor isoform A | 27 | 0 | 0 | 27 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 11 | 11 |
| Interferon beta | 90 | 0 | 0 | 90 |
| HLA class I histocompatibility antigen, B alpha chain | 71 | 0 | 0 | 71 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 2 | 0 | 2 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 71 | 0 | 0 | 71 |
| cytochrome P450 2C9, partial | 71 | 0 | 0 | 71 |
| M17 leucyl aminopeptidase | 0 | 1 | 0 | 1 |
| farnesoid X nuclear receptor | 80 | 0 | 0 | 80 |
| Solute carrier family 22 member 1 | 0 | 39 | 0 | 50 |
| Beta-2 adrenergic receptor | 0 | 36 | 26 | 63 |
| Beta-3 adrenergic receptor | 0 | 22 | 16 | 38 |
| SMAD family member 2 | 49 | 0 | 0 | 49 |
| SMAD family member 3 | 49 | 0 | 0 | 49 |
| caspase 7, apoptosis-related cysteine protease | 28 | 0 | 0 | 28 |
| caspase-3 | 28 | 0 | 0 | 28 |
| thyroid stimulating hormone receptor | 67 | 0 | 0 | 67 |
| thyrotropin-releasing hormone receptor | 15 | 0 | 0 | 15 |
| Caspase-7 | 15 | 0 | 0 | 15 |
| caspase-3 | 15 | 0 | 0 | 15 |
| EWS/FLI fusion protein | 74 | 0 | 0 | 74 |
| Solute carrier family 22 member 6 | 0 | 15 | 0 | 16 |
| Carbonic anhydrase 12 | 0 | 13 | 1 | 19 |
| UDP-glucuronosyltransferase 1A9 | 0 | 2 | 0 | 7 |
| Bile salt export pump | 0 | 28 | 0 | 28 |
| Cytochrome P450 2B1 | 0 | 1 | 0 | 2 |
| Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 46 | 1 | 56 |
| Carbonic anhydrase 2 | 0 | 49 | 2 | 61 |
| Myoglobin | 0 | 1 | 0 | 1 |
| Cytochrome P450 1A1 | 0 | 2 | 1 | 4 |
| Prostaglandin G/H synthase 1 | 0 | 24 | 0 | 25 |
| Carbonic anhydrase 3 | 0 | 10 | 1 | 15 |
| Cytochrome P450 3A4 | 0 | 43 | 2 | 49 |
| Cytochrome P450 2D6 | 0 | 37 | 1 | 38 |
| Cytochrome P450 2C9 | 0 | 45 | 0 | 46 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 10 | 0 | 10 |
| UDP-glucuronosyltransferase 1-6 | 0 | 6 | 0 | 8 |
| Arachidonate 5-lipoxygenase-activating protein | 0 | 3 | 0 | 3 |
| UDP-glucuronosyltransferase 1A1 | 0 | 7 | 0 | 10 |
| Carbonic anhydrase 4 | 0 | 27 | 1 | 32 |
| Prostaglandin G/H synthase 1 | 0 | 30 | 0 | 32 |
| Carbonic anhydrase 6 | 0 | 16 | 1 | 21 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 18 | 1 | 24 |
| Prostaglandin G/H synthase 2 | 0 | 31 | 3 | 38 |
| Carbonic anhydrase 7 | 0 | 13 | 1 | 18 |
| Cytochrome P450 2J2 | 0 | 29 | 0 | 30 |
| Carbonic anhydrase 9 | 0 | 23 | 1 | 30 |
| Carbonic anhydrase 15 | 0 | 13 | 0 | 16 |
| Carbonic anhydrase 13 | 0 | 9 | 0 | 13 |
| Carbonic anhydrase 14 | 0 | 11 | 1 | 17 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 14 | 1 | 20 |
| toxin B | 0 | 0 | 0 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
| Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
| Chain A, Beta-lactamase | 53 | 0 | 0 | 53 |
| Chain A, Endochitinase | 0 | 1 | 0 | 1 |
| Chain A, Endochitinase | 0 | 1 | 0 | 1 |
| Chain A, Endochitinase | 0 | 1 | 0 | 1 |
| Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 0 | 0 | 2 |
| Carbonic anhydrase | 0 | 6 | 0 | 6 |
| GALC protein | 16 | 0 | 0 | 16 |
| Carbonic anhydrase | 0 | 3 | 0 | 3 |
| Carbonic anhydrase | 0 | 5 | 0 | 5 |
| Carbonic anhydrase | 0 | 5 | 0 | 5 |
| muscleblind-like protein 1 isoform 1 | 26 | 0 | 0 | 26 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Prolyl endopeptidase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 2 |
| Glycogen phosphorylase, muscle form | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
| Cathepsin B | 0 | 1 | 0 | 1 |
| Steryl-sulfatase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 7 | 0 | 7 |
| Androgen receptor | 0 | 15 | 0 | 15 |
| Translocator protein | 0 | 5 | 2 | 8 |
| Cannabinoid receptor 1 | 0 | 7 | 4 | 11 |
| Cytochrome P450 2B6 | 0 | 3 | 2 | 5 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
| Serum paraoxonase/arylesterase 1 | 0 | 7 | 0 | 7 |
| Dipeptidyl peptidase 4 | 0 | 3 | 0 | 4 |
| Endochitinase | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 16 | 1 | 22 |
| Cytochrome P450 2C19 | 0 | 12 | 0 | 13 |
| Delta-type opioid receptor | 0 | 15 | 7 | 23 |
| Mu-type opioid receptor | 0 | 22 | 5 | 30 |
| Carbonic anhydrase | 0 | 14 | 0 | 16 |
| Kappa-type opioid receptor | 0 | 11 | 2 | 14 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 4 | 1 | 5 |
| Carbonic anhydrase | 0 | 3 | 0 | 6 |
| Cholinesterase | 0 | 7 | 0 | 7 |
| Carbonic anhydrase | 0 | 3 | 0 | 3 |
| Mu-type opioid receptor | 0 | 18 | 3 | 21 |
| Fatty-acid amide hydrolase 1 | 0 | 7 | 0 | 8 |
| Beta-carbonic anhydrase 1 | 0 | 4 | 0 | 4 |
| Carbonic anhydrase 2 | 0 | 3 | 0 | 3 |
| Squalene synthase | 0 | 3 | 0 | 3 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 7 | 3 | 11 |
| Carbonic anhydrase | 0 | 4 | 0 | 4 |
| Carbonic anhydrase, alpha family | 0 | 4 | 0 | 4 |
| Carbonic anhydrase | 0 | 4 | 0 | 7 |
| Carbonic anhydrase 3 | 0 | 3 | 0 | 3 |
| Carbonic anhydrase | 0 | 4 | 0 | 8 |
| Carbonic anhydrase | 0 | 5 | 0 | 9 |
| Carbonic anhydrase | 0 | 3 | 0 | 3 |
| Sigma intracellular receptor 2 | 0 | 8 | 0 | 8 |
| Delta carbonic anhydrase | 0 | 3 | 0 | 3 |
| Renin | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 2 | 0 | 5 |
| Endochitinase A1 | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 5 | 1 | 9 |
| Carbonic anhydrase 4 | 0 | 6 | 0 | 8 |
| Acidic mammalian chitinase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 3 | 0 | 3 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
| Urease | 0 | 5 | 0 | 6 |
| 72 kDa type IV collagenase | 0 | 4 | 0 | 4 |
| Stromelysin-1 | 0 | 1 | 4 | 5 |
| Urease subunit alpha | 0 | 5 | 0 | 5 |
| Lethal factor | 0 | 2 | 0 | 2 |
| Succinyl-diaminopimelate desuccinylase | 0 | 5 | 0 | 5 |
| Collagenase 3 | 0 | 3 | 0 | 4 |
| Peptide deformylase | 0 | 1 | 0 | 1 |
| Urease subunit beta | 0 | 5 | 0 | 5 |
| Urease subunit gamma | 0 | 1 | 0 | 1 |
| Urease subunit beta | 0 | 1 | 0 | 1 |
| Urease subunit alpha | 0 | 1 | 0 | 1 |
| Urease subunit beta | 0 | 2 | 0 | 2 |
| Histone deacetylase 1 | 0 | 6 | 0 | 6 |
| dopamine D1 receptor | 13 | 0 | 0 | 13 |
| Histone deacetylase 3 | 0 | 5 | 0 | 5 |
| Histone deacetylase 4 | 0 | 5 | 0 | 5 |
| Histone deacetylase 7 | 0 | 5 | 0 | 5 |
| Histone deacetylase 2 | 0 | 5 | 0 | 5 |
| Polyamine deacetylase HDAC10 | 0 | 5 | 0 | 5 |
| Histone deacetylase 11 | 0 | 5 | 0 | 5 |
| Histone deacetylase 8 | 0 | 5 | 0 | 5 |
| Histone deacetylase 6 | 0 | 5 | 0 | 5 |
| Histone deacetylase 9 | 0 | 5 | 0 | 5 |
| Histone deacetylase 5 | 0 | 5 | 0 | 5 |
| Testosterone 17-beta-dehydrogenase 3 | 0 | 2 | 0 | 2 |
| alpha-galactosidase | 19 | 0 | 0 | 19 |
| DNA topoisomerase 2-alpha | 0 | 2 | 1 | 9 |
| Chain A, MTA/SAH nucleosidase | 0 | 1 | 0 | 1 |
| Chain A, Ribosome-inactivating protein alpha-trichosanthin | 0 | 0 | 1 | 1 |
| Chain A, Ricin A chain | 0 | 0 | 1 | 1 |
| Chain A, Ribosome-inactivating protein 3 | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Phenylethanolamine N-methyltransferase | 0 | 0 | 1 | 1 |
| importin subunit beta-1 isoform 1 | 22 | 0 | 0 | 22 |
| snurportin-1 | 22 | 0 | 0 | 22 |
| tumor susceptibility gene 101 protein | 2 | 0 | 0 | 2 |
| GTP-binding nuclear protein Ran isoform 1 | 11 | 0 | 0 | 11 |
| Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
| Heat shock protein HSP 90-beta | 0 | 1 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 3 | 0 | 3 |
| Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
| Leucine-rich repeat serine/threonine-protein kinase 2 | 0 | 2 | 0 | 2 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 2 | 2 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 2 | 2 |
| Chain A, Membrane lipoprotein tmpC | 0 | 0 | 2 | 2 |
| Chain A, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
| Chain B, Structure of PAE2307 in complex with adenosine | 0 | 0 | 1 | 1 |
| Chain A, ADENOSINE RECEPTOR A2A | 0 | 2 | 0 | 2 |
| Chain A, ADENOSINE RECEPTOR A2A | 0 | 2 | 0 | 2 |
| Chain A, tRNA (guanine-N(1)-)-methyltransferase | 0 | 0 | 1 | 1 |
| Chain A, Uncharacterized protein MJ0883 | 0 | 0 | 1 | 1 |
| signal transducer and activator of transcription 6, interleukin-4 induced | 2 | 0 | 0 | 2 |
| NPYLR7B | 0 | 0 | 7 | 7 |
| glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 6 | 6 |
| high affinity choline transporter 1 isoform a | 0 | 2 | 0 | 2 |
| Sodium/nucleoside cotransporter 1 | 0 | 2 | 0 | 2 |
| Calcium dependent protein kinase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 2 | 2 |
| Sodium/nucleoside cotransporter 2 | 0 | 2 | 0 | 2 |
| Rap guanine nucleotide exchange factor 3 | 18 | 0 | 0 | 18 |
| Purine nucleoside phosphorylase | 0 | 1 | 0 | 2 |
| Epidermal growth factor receptor | 0 | 16 | 0 | 16 |
| Phosphoglycerate kinase 1 | 0 | 1 | 0 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Avidin | 0 | 0 | 1 | 1 |
| Adenosine deaminase | 0 | 0 | 0 | 1 |
| Glyceraldehyde-3-phosphate dehydrogenase | 0 | 3 | 0 | 3 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 7 | 0 | 7 |
| Insulin receptor | 0 | 0 | 0 | 1 |
| Phosphoglycerate kinase 2 | 0 | 1 | 0 | 1 |
| Heat shock protein HSP 90-alpha | 0 | 2 | 3 | 5 |
| Platelet-derived growth factor receptor beta | 0 | 0 | 0 | 1 |
| Heat shock 70 kDa protein 1A | 0 | 1 | 0 | 1 |
| Heat shock cognate 71 kDa protein | 0 | 0 | 1 | 1 |
| Fibroblast growth factor receptor 1 | 0 | 1 | 0 | 2 |
| Inosine-5'-monophosphate dehydrogenase 2 | 0 | 1 | 0 | 1 |
| Endoplasmin | 0 | 2 | 2 | 4 |
| Inosine-5'-monophosphate dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Fibroblast growth factor receptor 2 | 0 | 0 | 0 | 1 |
| Fibroblast growth factor receptor 4 | 0 | 0 | 0 | 1 |
| Fibroblast growth factor receptor 3 | 0 | 0 | 0 | 1 |
| Streptavidin | 0 | 0 | 1 | 1 |
| Adenosylhomocysteinase | 0 | 1 | 0 | 5 |
| Adenylate kinase 2, mitochondrial | 0 | 2 | 0 | 3 |
| Adenylate kinase isoenzyme 1 | 0 | 2 | 0 | 3 |
| Phosphatidylinositol 4-kinase alpha | 0 | 3 | 0 | 4 |
| Adenosine kinase | 0 | 0 | 0 | 1 |
| Adenosine deaminase | 0 | 1 | 0 | 2 |
| Equilibrative nucleoside transporter 2 | 0 | 2 | 0 | 2 |
| Phosphatidylinositol 4-kinase type 2-beta | 0 | 3 | 0 | 4 |
| Histone-lysine N-methyltransferase, H3 lysine-79 specific | 0 | 1 | 0 | 1 |
| Equilibrative nucleoside transporter 1 | 0 | 4 | 0 | 4 |
| Phosphatidylinositol 4-kinase type 2-alpha | 0 | 3 | 0 | 4 |
| Solute carrier family 28 member 3 | 0 | 3 | 0 | 3 |
| Adenosine kinase | 0 | 1 | 0 | 2 |
| Phosphatidylinositol 4-kinase beta | 0 | 3 | 0 | 4 |
| 5-methylthioadenosine/S-adenosylhomocysteine deaminase | 0 | 0 | 0 | 1 |
| Adenosine transporter 1 | 0 | 0 | 0 | 1 |
| Chain A, Glycogen Phosphorylase B | 0 | 0 | 1 | 1 |
| Chain B, Glycogen Phosphorylase B | 0 | 0 | 1 | 1 |
| Chain A, ADP-dependent glucokinase | 0 | 1 | 0 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Chain A, phosphodiesterase-nucleotide pyrophosphatase | 0 | 1 | 0 | 1 |
| Chain A, GLYCOGEN PHOSPHORYLASE B | 0 | 0 | 1 | 1 |
| Chain B, GLYCOGEN PHOSPHORYLASE B | 0 | 0 | 1 | 1 |
| Chain A, GLYCOGEN PHOSPHORYLASE B | 0 | 0 | 1 | 1 |
| 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | 0 | 1 | 0 | 1 |
| 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 1 | 2 |
| Transient receptor potential cation channel subfamily M member 2 | 0 | 1 | 0 | 1 |
| Alcohol dehydrogenase E chain | 0 | 3 | 1 | 4 |
| Alcohol dehydrogenase S chain | 0 | 3 | 1 | 4 |
| L-lactate dehydrogenase A chain | 0 | 5 | 1 | 6 |
| Adenylate kinase isoenzyme 1 | 0 | 0 | 0 | 1 |
| Fructose-1,6-bisphosphatase 1 | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 4 | 0 | 5 |
| Fructose-1,6-bisphosphatase 1 | 0 | 2 | 0 | 2 |
| 2-dehydropantoate 2-reductase | 0 | 1 | 1 | 2 |
| Inosine-5'-monophosphate dehydrogenase | 0 | 1 | 0 | 1 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 5 | 0 | 5 |
| Amine oxidase [flavin-containing] B | 0 | 4 | 0 | 5 |
| 5'-nucleotidase | 0 | 0 | 0 | 1 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| GTP:AMP phosphotransferase AK3, mitochondrial | 0 | 0 | 0 | 1 |
| P2Y purinoceptor 2 | 0 | 0 | 1 | 1 |
| P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
| P2Y purinoceptor 1 | 0 | 0 | 1 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 2 | 3 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 1 | 2 |
| Adenylate kinase 2, mitochondrial | 0 | 0 | 0 | 1 |
| Glycine--tRNA ligase | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 2 | 3 |
| Adenosine deaminase-like protein | 0 | 0 | 0 | 1 |
| Protease | 0 | 5 | 2 | 7 |
| P2Y purinoceptor 11 | 0 | 0 | 1 | 1 |
| Histamine H3 receptor | 0 | 3 | 0 | 3 |
| 5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 1 | 2 |
| 5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 1 | 2 |
| 5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 2 | 3 |
| Chain A, Endoplasmin | 0 | 0 | 1 | 1 |
| vasopressin V1b receptor | 2 | 0 | 0 | 2 |
| thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
| relaxin receptor 1 isoform 1 | 3 | 0 | 0 | 3 |
| relaxin receptor 2 isoform 1 | 2 | 0 | 0 | 2 |
| Transmembrane domain-containing protein TMIGD3 | 0 | 1 | 0 | 1 |
| Alpha-2B adrenergic receptor | 0 | 26 | 10 | 36 |
| Alpha-2C adrenergic receptor | 0 | 26 | 10 | 36 |
| Alpha-2A adrenergic receptor | 0 | 26 | 10 | 36 |
| Alpha-1A adrenergic receptor | 0 | 17 | 9 | 30 |
| Alpha-synuclein | 16 | 7 | 0 | 23 |
| Aflatoxin B1 aldehyde reductase member 3 | 0 | 1 | 0 | 1 |
| Endoplasmin | 0 | 0 | 1 | 1 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Endoplasmin | 0 | 0 | 1 | 1 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Adenosine receptor A3 | 0 | 1 | 1 | 2 |
| 2-oxoglutarate receptor 1 | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 66 | 7 | 74 |
| RGS12 | 2 | 0 | 0 | 2 |
| Fumarate hydratase | 36 | 0 | 0 | 36 |
| nonstructural protein 1 | 24 | 0 | 0 | 24 |
| polyprotein | 36 | 0 | 0 | 36 |
| atrial natriuretic peptide receptor 1 precursor | 14 | 0 | 0 | 14 |
| guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | 2 | 0 | 0 | 2 |
| atrial natriuretic peptide receptor 2 precursor | 18 | 0 | 0 | 18 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 17 | 0 | 0 | 17 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 26 | 0 | 0 | 26 |
| High affinity nerve growth factor receptor | 0 | 2 | 2 | 4 |
| Amyloid-beta precursor protein | 4 | 4 | 0 | 8 |
| Ephrin type-A receptor 3 | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 7 | 0 | 7 |
| 60 kDa heat shock protein, mitochondrial | 0 | 11 | 0 | 11 |
| 10 kDa heat shock protein, mitochondrial | 0 | 11 | 0 | 11 |
| Thiosulfate sulfurtransferase | 0 | 10 | 0 | 10 |
| Beta-2 adrenergic receptor | 0 | 1 | 11 | 20 |
| 60 kDa chaperonin | 0 | 12 | 0 | 12 |
| 10 kDa chaperonin | 0 | 12 | 0 | 12 |
| Beta-2 adrenergic receptor | 0 | 10 | 15 | 27 |
| ATP-dependent translocase ABCB1 | 0 | 49 | 4 | 71 |
| Chain A, Xcogt | 0 | 0 | 1 | 1 |
| Chain A, Xcogt | 0 | 0 | 1 | 1 |
| Chain A, Xcogt | 0 | 0 | 1 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 12 | 1 | 0 | 13 |
| Botulinum neurotoxin type A | 0 | 2 | 0 | 2 |
| Neutrophil cytosol factor 1 | 0 | 2 | 0 | 2 |
| Nitric oxide synthase, endothelial | 0 | 4 | 0 | 4 |
| Nitric oxide synthase, brain | 0 | 5 | 0 | 6 |
| Nitric oxide synthase, brain | 0 | 4 | 0 | 6 |
| Nitric oxide synthase, inducible | 0 | 4 | 1 | 8 |
| Tyrosine-protein kinase | 0 | 0 | 1 | 1 |
| WRN | 2 | 0 | 0 | 2 |
| phospholipase A2 precursor | 0 | 1 | 0 | 1 |
| cysteine protease ATG4B isoform a | 0 | 1 | 0 | 1 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 6 | 0 | 0 | 6 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | 3 | 0 | 0 | 3 |
| Free fatty acid receptor 1 | 0 | 0 | 1 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 10 | 0 | 14 |
| Trypsin | 0 | 2 | 0 | 2 |
| Coagulation factor VII | 0 | 3 | 0 | 3 |
| Aromatase | 0 | 3 | 0 | 3 |
| Tissue factor | 0 | 4 | 0 | 4 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 5 | 5 |
| Prostaglandin G/H synthase 2 | 0 | 15 | 0 | 16 |
| Free fatty acid receptor 4 | 0 | 0 | 1 | 1 |
| Alpha-2A adrenergic receptor | 0 | 76 | 9 | 90 |
| Beta-2 adrenergic receptor | 0 | 6 | 1 | 11 |
| Alpha-2B adrenergic receptor | 0 | 66 | 4 | 75 |
| Beta-1 adrenergic receptor | 0 | 8 | 5 | 18 |
| Alpha-2C adrenergic receptor | 0 | 51 | 6 | 62 |
| Alpha-1D adrenergic receptor | 0 | 57 | 7 | 68 |
| Spike glycoprotein | 81 | 2 | 6 | 89 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 3 | 0 | 3 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 3 | 1 | 4 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 3 | 0 | 3 |
| Prostacyclin receptor | 0 | 5 | 2 | 7 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 1 | 2 | 3 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 3 | 1 | 4 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 3 | 0 | 8 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 3 |
| Solute carrier organic anion transporter family member 3A1 | 0 | 0 | 0 | 1 |
| putative alpha-glucosidase | 1 | 0 | 0 | 1 |
| Solute carrier family 22 member 2 | 0 | 21 | 0 | 27 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 4 | 0 | 4 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 4 | 0 | 4 |
| Matrix protein 2 | 0 | 1 | 2 | 3 |
| Matrix protein 2 | 0 | 2 | 3 | 5 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 7 | 0 | 7 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 7 | 0 | 7 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 6 | 0 | 6 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 4 | 0 | 4 |
| Solute carrier family 22 member 1 | 0 | 19 | 0 | 23 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 4 | 0 | 4 |
| Multidrug and toxin extrusion protein 1 | 0 | 29 | 0 | 29 |
| Solute carrier family 22 member 2 | 0 | 16 | 0 | 18 |
| Aminopeptidase N | 0 | 1 | 0 | 1 |
| Aminopeptidase N | 0 | 2 | 0 | 2 |
| Cytosol aminopeptidase | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 7 | 0 | 7 |
| Leucyl-cystinyl aminopeptidase | 0 | 1 | 0 | 1 |
| Glutamyl aminopeptidase | 0 | 1 | 0 | 1 |
| Leukotriene B4 receptor 1 | 0 | 5 | 1 | 7 |
| Lysosomal acid glucosylceramidase | 0 | 1 | 1 | 2 |
| aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 2 |
| apical membrane antigen 1, AMA1 | 12 | 0 | 0 | 12 |
| transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 2 |
| Glutaminyl-peptide cyclotransferase | 0 | 3 | 0 | 3 |
| Guanine deaminase | 0 | 2 | 0 | 2 |
| interleukin 8 | 23 | 0 | 0 | 23 |
| Nicotinate phosphoribosyltransferase | 0 | 7 | 0 | 7 |
| ORF73 | 0 | 0 | 4 | 4 |
| microphthalmia-associated transcription factor isoform 9 | 0 | 2 | 0 | 2 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 3 | 1 | 6 |
| PPM1D protein | 21 | 0 | 0 | 21 |
| urokinase-type plasminogen activator precursor | 23 | 0 | 0 | 23 |
| plasminogen precursor | 23 | 0 | 0 | 23 |
| urokinase plasminogen activator surface receptor precursor | 23 | 0 | 0 | 23 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 10 | 0 | 10 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 5 | 0 | 9 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 23 | 0 | 23 |
| 5-hydroxytryptamine receptor 4 | 0 | 74 | 1 | 75 |
| Lysine-specific demethylase PHF2 | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor alpha | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 8 | 0 | 8 |
| ATP-dependent translocase ABCB1 | 0 | 17 | 0 | 17 |
| Aldo-keto reductase family 1 member B1 | 0 | 50 | 0 | 50 |
| Thyroid hormone receptor alpha | 0 | 1 | 1 | 2 |
| Thyroid hormone receptor beta | 0 | 1 | 1 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 18 | 0 | 19 |
| Substance-K receptor | 0 | 20 | 1 | 22 |
| D(1A) dopamine receptor | 0 | 47 | 1 | 49 |
| D(4) dopamine receptor | 0 | 19 | 1 | 22 |
| Carnitine O-palmitoyltransferase 2, mitochondrial | 0 | 1 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 57 | 3 | 60 |
| Histamine H2 receptor | 0 | 33 | 3 | 36 |
| Endothelin-1 receptor | 0 | 7 | 1 | 9 |
| Lysine-specific demethylase 5A | 0 | 2 | 0 | 2 |
| B2 bradykinin receptor | 0 | 6 | 1 | 9 |
| Melanocortin receptor 4 | 0 | 6 | 0 | 6 |
| C-8 sterol isomerase | 0 | 4 | 0 | 4 |
| Melanocortin receptor 5 | 0 | 8 | 0 | 8 |
| D(3) dopamine receptor | 0 | 65 | 2 | 69 |
| Sodium channel protein type 1 subunit alpha | 0 | 9 | 0 | 9 |
| Sodium channel protein type 4 subunit alpha | 0 | 11 | 0 | 13 |
| Squalene synthase | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 22 | 3 | 27 |
| Kappa-type opioid receptor | 0 | 21 | 4 | 27 |
| C-C chemokine receptor type 2 | 0 | 6 | 0 | 6 |
| Melanocortin receptor 3 | 0 | 6 | 0 | 6 |
| Carnitine O-palmitoyltransferase 1, liver isoform | 0 | 1 | 0 | 1 |
| C-C chemokine receptor type 4 | 0 | 4 | 0 | 4 |
| Sodium channel protein type 7 subunit alpha | 0 | 8 | 0 | 8 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 23 | 0 | 23 |
| Sodium-dependent dopamine transporter | 0 | 47 | 0 | 47 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 76 | 1 | 77 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 23 | 0 | 23 |
| Sodium channel protein type 5 subunit alpha | 0 | 17 | 0 | 17 |
| Squalene monooxygenase | 0 | 1 | 0 | 1 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 5 | 1 | 6 |
| Sodium channel protein type 9 subunit alpha | 0 | 14 | 0 | 14 |
| Lysine-specific demethylase 7A | 0 | 1 | 0 | 1 |
| Carnitine O-palmitoyltransferase 1, muscle isoform | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 10 | 0 | 10 |
| Sigma non-opioid intracellular receptor 1 | 0 | 44 | 2 | 46 |
| NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 0 | 0 | 1 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 11 | 0 | 11 |
| Sodium channel protein type 11 subunit alpha | 0 | 7 | 0 | 7 |
| Histone lysine demethylase PHF8 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 8 subunit alpha | 0 | 8 | 0 | 8 |
| Sodium channel protein type 10 subunit alpha | 0 | 7 | 0 | 7 |
| Albumin | 0 | 0 | 9 | 9 |
| Angiotensin-converting enzyme | 0 | 38 | 0 | 39 |
| D(1B) dopamine receptor | 0 | 6 | 0 | 7 |
| UDP-glucuronosyltransferase 1A4 | 0 | 5 | 0 | 12 |
| Histamine H1 receptor | 0 | 13 | 1 | 14 |
| UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 9 |
| 5-hydroxytryptamine receptor 7 | 0 | 21 | 0 | 21 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 6 | 0 | 6 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 30 | 0 | 30 |
| Histamine H3 receptor | 0 | 6 | 2 | 8 |
| hypothetical protein, conserved | 10 | 0 | 0 | 10 |
| pyruvate kinase | 4 | 0 | 0 | 4 |
| nuclear receptor subfamily 1, group I, member 2 | 19 | 0 | 0 | 19 |
| Replicase polyprotein 1ab | 0 | 3 | 7 | 10 |
| lysosomal alpha-glucosidase preproprotein | 13 | 0 | 0 | 13 |
| NPC intracellular cholesterol transporter 1 precursor | 14 | 0 | 0 | 14 |
| pyruvate kinase PKM isoform a | 3 | 0 | 0 | 3 |
| Transthyretin | 0 | 1 | 4 | 8 |
| Neuronal acetylcholine receptor subunit alpha-4 | 7 | 10 | 4 | 22 |
| Neuronal acetylcholine receptor subunit beta-2 | 7 | 10 | 4 | 22 |
| Endothelin receptor type B | 1 | 2 | 0 | 3 |
| Endothelin-1 receptor | 1 | 1 | 0 | 2 |
| Inhibitor of nuclear factor kappa-B kinase subunit epsilon | 0 | 1 | 0 | 1 |
| G-protein coupled receptor 35 | 0 | 1 | 5 | 6 |
| Serine/threonine-protein kinase TBK1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 2 | 0 | 2 |
| Phenylethanolamine N-methyltransferase | 0 | 2 | 0 | 2 |
| Substance-P receptor | 0 | 3 | 1 | 4 |
| Sodium-dependent dopamine transporter | 0 | 16 | 0 | 16 |
| Sigma non-opioid intracellular receptor 1 | 0 | 8 | 2 | 10 |
| tumor necrosis factor | 3 | 0 | 0 | 3 |
| Aurora kinase B | 0 | 2 | 0 | 2 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 13 | 1 | 15 |
| Chain A, Mutant Al2 6e7p9g | 0 | 0 | 1 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| acid sphingomyelinase | 7 | 0 | 0 | 7 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase type 2 | 0 | 1 | 1 | 3 |
| Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase OXA-7 | 0 | 0 | 0 | 3 |
| Solute carrier family 15 member 1 | 0 | 8 | 0 | 8 |
| Solute carrier family 15 member 1 | 0 | 4 | 0 | 4 |
| Angiopoietin-1 receptor | 0 | 0 | 2 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Solute carrier family 15 member 2 | 0 | 3 | 0 | 3 |
| Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 2 |
| Efflux transporter | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase Toho-1 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Class D beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
| Solute carrier family 15 member 2 | 0 | 3 | 0 | 4 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-b-lactamase | 0 | 0 | 0 | 1 |
| Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 1 |
| Histamine H3 receptor | 0 | 1 | 0 | 3 |
| Beta-lactamase class B VIM-2 | 0 | 1 | 1 | 3 |
| Beta-lactamase VIM-1 | 0 | 1 | 0 | 2 |
| Fatty-acid amide hydrolase 1 | 0 | 6 | 0 | 6 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 2 |
| Potassium channel subfamily K member 3 | 0 | 6 | 0 | 6 |
| Fatty acid-binding protein, liver | 0 | 3 | 0 | 3 |
| Glutamate receptor 1 | 2 | 1 | 2 | 7 |
| Glutamate receptor 3 | 2 | 1 | 2 | 7 |
| Glutamate receptor 4 | 2 | 1 | 2 | 7 |
| Cannabinoid receptor 1 | 0 | 10 | 3 | 19 |
| Cannabinoid receptor 2 | 0 | 6 | 2 | 13 |
| Cannabinoid receptor 1 | 0 | 5 | 1 | 6 |
| Cannabinoid receptor 2 | 0 | 2 | 2 | 4 |
| Fatty acid-binding protein 5 | 0 | 0 | 2 | 2 |
| Corticotropin-releasing factor receptor 2 | 0 | 2 | 0 | 2 |
| Lanosterol 14-alpha demethylase | 0 | 5 | 0 | 5 |
| Potassium channel subfamily K member 2 | 0 | 3 | 0 | 3 |
| Transient receptor potential cation channel subfamily V member 1 | 0 | 4 | 3 | 9 |
| Cannabinoid receptor 2 | 0 | 3 | 0 | 3 |
| Transient receptor potential cation channel subfamily V member 2 | 0 | 4 | 2 | 6 |
| Atrial natriuretic peptide receptor 3 | 0 | 2 | 0 | 2 |
| Type-1A angiotensin II receptor | 0 | 4 | 2 | 6 |
| Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
| Type-1B angiotensin II receptor | 0 | 4 | 0 | 4 |
| Type-1 angiotensin II receptor | 0 | 5 | 4 | 11 |
| Type-2 angiotensin II receptor | 0 | 8 | 0 | 8 |
| Type-2 angiotensin II receptor | 0 | 3 | 0 | 3 |
| Chain A, ADIPOCYTE LIPID-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
| Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 14 | 0 | 0 | 14 |
| caspase-1 isoform alpha precursor | 7 | 0 | 0 | 7 |
| Fatty acid-binding protein, adipocyte | 0 | 3 | 1 | 4 |
| Calmodulin | 0 | 0 | 2 | 3 |
| Fatty acid-binding protein 5 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 19 | 0 | 21 |
| Cytosolic phospholipase A2 gamma | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 17 | 0 | 19 |
| Muscarinic acetylcholine receptor M1 | 0 | 3 | 5 | 10 |
| Muscarinic acetylcholine receptor M3 | 0 | 1 | 3 | 8 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 1 | 8 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
| Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
| Nitric oxide synthase, endothelial | 0 | 2 | 0 | 4 |
| Nitric oxide synthase, inducible | 0 | 4 | 0 | 5 |
| Cationic amino acid transporter 3 | 0 | 2 | 0 | 2 |
| Monoglyceride lipase | 0 | 1 | 0 | 1 |
| Ectonucleoside triphosphate diphosphohydrolase 3 | 0 | 1 | 0 | 1 |
| Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 | 0 | 1 | 0 | 1 |
| Ectonucleoside triphosphate diphosphohydrolase 1 | 0 | 1 | 0 | 1 |
| Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
| Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
| Albumin | 0 | 3 | 0 | 4 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
| Tyrosinase | 0 | 1 | 0 | 1 |
| Hyaluronate lyase | 0 | 1 | 0 | 1 |
| Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
| Egl nine homolog 1 | 0 | 0 | 0 | 1 |
| Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
| Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
| Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
| GTP-binding protein (rab7) | 0 | 0 | 3 | 3 |
| ras protein, partial | 0 | 0 | 3 | 3 |
| Rac1 protein | 0 | 0 | 3 | 3 |
| cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 3 | 3 |
| Prostaglandin-H2 D-isomerase | 0 | 3 | 0 | 3 |
| Prostaglandin G/H synthase 2 | 0 | 8 | 0 | 11 |
| Fatty acid-binding protein, liver | 0 | 9 | 0 | 9 |
| Myeloperoxidase | 0 | 5 | 0 | 5 |
| Seed linoleate 13S-lipoxygenase-1 | 0 | 5 | 0 | 5 |
| Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
| Substance-P receptor | 0 | 6 | 0 | 6 |
| Urotensin-2 receptor | 0 | 2 | 0 | 2 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 2 | 0 | 2 |
| Ras-related protein Rab-2A | 0 | 0 | 3 | 3 |
| Rho-associated protein kinase 2 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 20 | 0 | 6 | 0 | 6 |
| Solute carrier family 22 member 6 | 0 | 6 | 0 | 6 |
| Spike glycoprotein | 0 | 2 | 6 | 8 |
| ubiquitin-conjugating enzyme E2 N | 0 | 4 | 0 | 4 |
| Transmembrane protease serine 2 | 0 | 2 | 6 | 8 |
| Polycomb protein EED | 0 | 2 | 0 | 2 |
| HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 2 | 2 |
| Tyrosine-protein kinase Lck | 0 | 3 | 0 | 3 |
| Procathepsin L | 0 | 6 | 6 | 12 |
| Replicase polyprotein 1a | 0 | 2 | 7 | 9 |
| Replicase polyprotein 1ab | 0 | 2 | 6 | 8 |
| Replicase polyprotein 1ab | 0 | 6 | 6 | 12 |
| Replicase polyprotein 1ab | 0 | 11 | 6 | 17 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 4 | 4 |
| Substance-P receptor | 0 | 14 | 2 | 16 |
| Somatostatin receptor type 2 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 4 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 3 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 5 | 0 | 1 | 0 | 1 |
| Sigma intracellular receptor 2 | 0 | 5 | 0 | 5 |
| Angiotensin-converting enzyme 2 | 0 | 5 | 6 | 11 |
| Histamine H4 receptor | 0 | 13 | 3 | 16 |
| Heparanase | 0 | 0 | 3 | 3 |
| Beta-1 adrenergic receptor | 0 | 1 | 10 | 13 |
| Amine oxidase [flavin-containing] A | 0 | 3 | 1 | 5 |
| Small conductance calcium-activated potassium channel protein 3 | 0 | 1 | 1 | 2 |
| Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
| Atrial natriuretic peptide receptor 1 | 0 | 0 | 1 | 1 |
| cystic fibrosis transmembrane conductance regulator | 0 | 2 | 0 | 2 |
| short transient receptor potential channel 6 isoform 1 | 0 | 0 | 2 | 2 |
| Muscarinic acetylcholine receptor M4 | 0 | 3 | 1 | 5 |
| Reverse transcriptase/RNaseH | 0 | 2 | 2 | 8 |
| P53 | 1 | 0 | 0 | 1 |
| hemoglobin subunit beta | 2 | 0 | 0 | 2 |
| Protein-arginine deiminase type-4 | 0 | 6 | 0 | 6 |
| Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 2 | 2 | 4 |
| Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 2 | 2 | 4 |
| Acetylcholinesterase | 0 | 8 | 0 | 8 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Carboxylic ester hydrolase | 0 | 1 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 8 | 0 | 9 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 5 | 0 | 6 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 5 | 0 | 6 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 4 | 4 |
| Rap guanine nucleotide exchange factor 4 | 8 | 0 | 0 | 8 |
| beta-2 adrenergic receptor | 11 | 0 | 1 | 12 |
| galanin receptor type 3 | 0 | 3 | 0 | 3 |
| Glucocorticoid receptor | 0 | 21 | 3 | 29 |
| Glycine receptor subunit alpha-1 | 0 | 20 | 0 | 20 |
| Glycine receptor subunit beta | 0 | 20 | 0 | 20 |
| Glycine receptor subunit alpha-2 | 0 | 20 | 0 | 20 |
| Glycine receptor subunit alpha-3 | 0 | 20 | 0 | 20 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 11 | 0 | 11 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 11 | 0 | 11 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 15 | 8 | 23 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 11 | 3 | 14 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 14 | 8 | 22 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 14 | 5 | 19 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 12 | 6 | 18 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 12 | 5 | 17 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 12 | 6 | 18 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 12 | 7 | 19 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 11 | 3 | 14 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 11 | 0 | 11 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 11 | 3 | 14 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 11 | 0 | 11 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 11 | 0 | 11 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 11 | 0 | 11 |
| Beta-1 adrenergic receptor | 0 | 5 | 1 | 6 |
| Multidrug resistance-associated protein 6 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 3 |
| Endothelin receptor type B | 0 | 4 | 0 | 4 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 3 | 0 | 6 |
| Endothelin-1 receptor | 0 | 3 | 0 | 3 |
| Canalicular multispecific organic anion transporter 1 | 0 | 6 | 0 | 9 |
| Solute carrier organic anion transporter family member 1B2 | 0 | 1 | 0 | 3 |
| Angiotensin-converting enzyme | 0 | 11 | 1 | 13 |
| B2 bradykinin receptor | 0 | 1 | 0 | 1 |
| B1 bradykinin receptor | 0 | 1 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 1 | 3 | 4 |
| Alkaline phosphatase, germ cell type | 0 | 3 | 0 | 3 |
| Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 2 | 0 | 3 | 5 | 8 |
| Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
| ClpP | 5 | 0 | 0 | 5 |
| electroneutral potassium-chloride cotransporter KCC2 | 0 | 0 | 1 | 1 |
| TSHR protein | 2 | 0 | 0 | 2 |
| Parkin | 18 | 0 | 0 | 18 |
| LacZ protein (plasmid) | 0 | 0 | 2 | 2 |
| XBP1 | 0 | 2 | 0 | 2 |
| serine-protein kinase ATM isoform a | 5 | 0 | 0 | 5 |
| type-1 angiotensin II receptor | 0 | 2 | 0 | 2 |
| apelin receptor | 0 | 2 | 0 | 2 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 2 | 0 | 4 |
| DNA damage-inducible transcript 3 protein | 0 | 2 | 0 | 2 |
| Vpr | 8 | 0 | 0 | 8 |
| streptokinase A precursor | 0 | 0 | 8 | 8 |
| HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
| heat shock protein 90, putative | 0 | 0 | 0 | 2 |
| transient receptor potential cation channel subfamily V member 1 | 4 | 0 | 0 | 4 |
| Transient receptor potential cation channel subfamily V member 1 | 0 | 5 | 2 | 7 |
| Lysine-specific histone demethylase 1A | 0 | 2 | 0 | 2 |
| NADH-ubiquinone oxidoreductase chain 1 | 0 | 2 | 0 | 2 |
| Potassium voltage-gated channel subfamily A member 1 | 0 | 3 | 1 | 4 |
| Transient receptor potential cation channel subfamily V member 4 | 0 | 2 | 2 | 4 |
| Transient receptor potential cation channel subfamily M member 8 | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily M member 8 | 0 | 1 | 0 | 1 |
| Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
| Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 1 | 0 | 2 |
| Neprilysin | 0 | 1 | 0 | 1 |
| Neprilysin | 0 | 2 | 0 | 2 |
| Leukotriene A-4 hydrolase | 0 | 4 | 1 | 6 |
| EEF1AKMT4-ECE2 readthrough transcript protein | 0 | 1 | 0 | 1 |
| Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Thymidine phosphorylase | 0 | 0 | 1 | 1 |
| Endothelin-converting enzyme 1 | 0 | 1 | 0 | 1 |
| Beta-lactamase TEM | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 3 | 0 | 4 |
| Beta-lactamase | 0 | 3 | 0 | 3 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 4 | 3 | 8 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 4 | 3 | 8 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 4 | 3 | 8 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 4 | 3 | 8 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 4 | 3 | 8 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 4 | 3 | 8 |
| Neuronal acetylcholine receptor subunit alpha-9 | 0 | 4 | 3 | 8 |
| Neuronal acetylcholine receptor subunit alpha-10 | 0 | 4 | 3 | 8 |
| Major prion protein | 0 | 0 | 4 | 4 |
| Sodium channel protein type 1 subunit alpha | 0 | 4 | 0 | 4 |
| Sodium channel protein type 2 subunit alpha | 0 | 6 | 0 | 6 |
| Sodium channel protein type 3 subunit alpha | 0 | 4 | 0 | 4 |
| UDP-glucuronosyltransferase 2B7 | 0 | 7 | 0 | 17 |
| Frizzled-8 | 0 | 0 | 1 | 1 |
| P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
| Vasopressin V2 receptor | 0 | 1 | 2 | 3 |
| Oxytocin receptor | 0 | 3 | 3 | 6 |
| Vasopressin V1a receptor | 0 | 4 | 3 | 7 |
| Vasopressin V1b receptor | 0 | 1 | 2 | 3 |
| Oxytocin receptor | 0 | 0 | 2 | 2 |
| Kinesin-like protein KIF11 | 0 | 1 | 0 | 1 |
| Chain A, serum paraoxonase | 0 | 1 | 0 | 1 |
| Poly [ADP-ribose] polymerase tankyrase-2 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 16 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 21 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 9 | 0 | 13 |
| Solute carrier family 22 member 8 | 0 | 8 | 0 | 14 |
| Solute carrier family 22 member 11 | 0 | 2 | 0 | 7 |
| Solute carrier family 22 member 8 | 0 | 4 | 0 | 4 |
| Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
| interferon gamma precursor | 0 | 0 | 0 | 2 |
| prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 2 |
| Prostaglandin E synthase | 0 | 3 | 0 | 3 |
| 3-phosphoinositide-dependent protein kinase 1 | 0 | 1 | 0 | 1 |
| Cytochrome c oxidase subunit 1 | 0 | 1 | 0 | 1 |
| Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
| Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
| Cytochrome c oxidase subunit 2 | 0 | 4 | 0 | 4 |
| Quinolone resistance protein NorA | 0 | 3 | 0 | 4 |
| Calpain-2 catalytic subunit | 0 | 2 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
| Cruzipain | 0 | 4 | 0 | 4 |
| Sodium/hydrogen exchanger 1 | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 3 | 0 | 3 |
| Bifunctional epoxide hydrolase 2 | 0 | 7 | 0 | 7 |
| Prostaglandin G/H synthase 2 | 0 | 14 | 0 | 17 |
| Prostaglandin G/H synthase 2 | 0 | 9 | 0 | 10 |
| Mitogen-activated protein kinase 14 | 0 | 5 | 0 | 5 |
| Prostaglandin G/H synthase 1 | 0 | 15 | 0 | 18 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Cyclooxygenase-2 | 0 | 2 | 0 | 2 |
| P2Y purinoceptor 12 | 0 | 3 | 0 | 3 |
| B2 metallo-beta-lactamase | 0 | 0 | 0 | 1 |
| Caspase-2 | 0 | 0 | 1 | 1 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 3 | 3 |
| D(3) dopamine receptor isoform e | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 2 | 2 |
| FAD-linked sulfhydryl oxidase ALR | 0 | 0 | 0 | 1 |
| Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 2 |
| 30S ribosomal protein S6 | 0 | 5 | 1 | 6 |
| 30S ribosomal protein S7 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L15 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L10 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L11 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L7/L12 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L19 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L1 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L20 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L27 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L28 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L29 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L31 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L31 type B | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L32 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L33 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L34 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L35 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L36 | 0 | 5 | 1 | 6 |
| 30S ribosomal protein S10 | 0 | 5 | 1 | 6 |
| 30S ribosomal protein S11 | 0 | 5 | 1 | 6 |
| 30S ribosomal protein S12 | 0 | 5 | 1 | 6 |
| 30S ribosomal protein S13 | 0 | 5 | 1 | 6 |
| 30S ribosomal protein S16 | 0 | 5 | 1 | 6 |
| 30S ribosomal protein S18 | 0 | 5 | 1 | 6 |
| 30S ribosomal protein S19 | 0 | 5 | 1 | 6 |
| 30S ribosomal protein S20 | 0 | 5 | 1 | 6 |
| 30S ribosomal protein S2 | 0 | 5 | 1 | 6 |
| 30S ribosomal protein S3 | 0 | 5 | 1 | 6 |
| 30S ribosomal protein S4 | 0 | 5 | 1 | 6 |
| 30S ribosomal protein S5 | 0 | 5 | 1 | 6 |
| 30S ribosomal protein S8 | 0 | 5 | 1 | 6 |
| 30S ribosomal protein S9 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L13 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L14 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L16 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L23 | 0 | 5 | 1 | 6 |
| 30S ribosomal protein S15 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L17 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L21 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L30 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L6 | 0 | 5 | 1 | 6 |
| 30S ribosomal protein S14 | 0 | 5 | 1 | 6 |
| 30S ribosomal protein S17 | 0 | 5 | 1 | 6 |
| 30S ribosomal protein S1 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L18 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L2 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L3 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L24 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L4 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L22 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L5 | 0 | 5 | 1 | 6 |
| 30S ribosomal protein S21 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L25 | 0 | 5 | 1 | 6 |
| 50S ribosomal protein L36 2 | 0 | 5 | 1 | 6 |
| Methionine--tRNA ligase, mitochondrial | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 6 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 6 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 6 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 6 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 6 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 6 | 0 | 8 |
| Cholecystokinin receptor type A | 0 | 3 | 0 | 3 |
| Gastrin/cholecystokinin type B receptor | 0 | 3 | 1 | 4 |
| Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 1 | 1 |
| PAX8 | 0 | 0 | 0 | 3 |
| PINK1 | 3 | 0 | 0 | 3 |
| heat shock protein 90 | 0 | 0 | 1 | 1 |
| calcineurin A1, putative | 0 | 0 | 1 | 1 |
| hepatocyte nuclear factor 4-alpha isoform 2 | 0 | 4 | 0 | 4 |
| perilipin-5 | 0 | 6 | 0 | 6 |
| perilipin-1 | 0 | 6 | 0 | 6 |
| protein AF-9 isoform a | 0 | 0 | 0 | 3 |
| melanocortin receptor 4 | 0 | 1 | 0 | 1 |
| CAAX prenyl protease | 0 | 0 | 0 | 1 |
| bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 6 | 0 | 6 |
| glycogen synthase kinase-3 alpha | 0 | 0 | 0 | 1 |
| hexokinase HKDC1 | 0 | 1 | 0 | 1 |
| DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 4 |
| bcl-2-like protein 11 isoform 1 | 0 | 0 | 1 | 1 |
| Synaptojanin-2 | 0 | 1 | 0 | 1 |
| Synaptojanin-1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 9 | 0 | 10 |
| Glutathione reductase, mitochondrial | 0 | 8 | 0 | 10 |
| Matrix metalloproteinase-9 | 0 | 2 | 0 | 2 |
| Trypanothione reductase | 0 | 5 | 0 | 5 |
| Peroxisomal N(1)-acetyl-spermine/spermidine oxidase | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 2 | 0 | 14 | 0 | 14 |
| Spermine oxidase | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B10 | 0 | 5 | 0 | 5 |
| MBT domain-containing protein 1 | 0 | 2 | 0 | 2 |
| Lethal(3)malignant brain tumor-like protein 4 | 0 | 2 | 0 | 2 |
| Lethal(3)malignant brain tumor-like protein 3 | 0 | 2 | 0 | 2 |
| Chloroquine resistance transporter | 0 | 3 | 0 | 3 |
| Lethal(3)malignant brain tumor-like protein 1 | 0 | 2 | 0 | 2 |
| Snq2p | 0 | 0 | 0 | 5 |
| Pleiotropic ABC efflux transporter of multiple drugs | 0 | 5 | 0 | 10 |
| Vitamin D3 receptor | 0 | 1 | 1 | 4 |
| Vitamin D3 receptor | 0 | 0 | 1 | 1 |
| Chain A, Acetylcholinesterase | 0 | 0 | 2 | 2 |
| Chain A, Acetylcholinesterase | 0 | 0 | 2 | 2 |
| Chain A, Acetylcholinesterase | 0 | 0 | 2 | 2 |
| Chain A, Acetylcholinesterase | 0 | 0 | 2 | 2 |
| Chain A, Acetylcholinesterase | 0 | 0 | 2 | 2 |
| Chain A, Acetylcholinesterase | 0 | 0 | 2 | 2 |
| Chain A, Acetylcholinesterase | 0 | 0 | 2 | 2 |
| Chain A, Putative Glycine Betaine-binding Abc Transporter Protein | 0 | 0 | 1 | 1 |
| Chain A, PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER PROTEIN | 0 | 0 | 1 | 1 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
| Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 1 | 1 |
| Chain A, Choline-binding protein | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 1 | 0 | 3 | 0 | 4 |
| Solute carrier family 22 member 2 | 0 | 3 | 0 | 3 |
| Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
| Choline O-acetyltransferase | 0 | 0 | 0 | 1 |
| High affinity choline transporter 1 | 0 | 1 | 0 | 1 |
| alternatively spliced Trp4 | 0 | 0 | 1 | 1 |
| delta-type opioid receptor | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 5A | 0 | 0 | 1 | 1 |
| Galanin receptor type 2 | 0 | 0 | 1 | 1 |
| Trypanothione reductase | 0 | 1 | 0 | 1 |
| M1-family alanyl aminopeptidase | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 4 | 0 | 4 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 4 | 0 | 4 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 4 | 0 | 4 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 4 | 0 | 4 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 4 | 0 | 4 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 4 | 0 | 4 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 4 | 0 | 4 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 4 | 0 | 4 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 4 | 0 | 4 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 4 | 0 | 4 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 4 | 0 | 4 |
| Chain B, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 4 | 0 | 4 |
| Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 4 | 0 | 4 |
| Chain A, cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 4 | 0 | 4 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 17 | 1 | 19 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 14 | 0 | 14 |
| Phosphodiesterase | 0 | 3 | 0 | 3 |
| Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A | 0 | 7 | 0 | 7 |
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 8 | 0 | 9 |
| Potassium-transporting ATPase alpha chain 1 | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 5 | 4 | 10 |
| Potassium-transporting ATPase subunit beta | 0 | 1 | 0 | 1 |
| Aldehyde oxidase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 4 | 0 | 3 | 0 | 3 |
| chaperonin-containing TCP-1 beta subunit homolog | 4 | 0 | 0 | 4 |
| Estrogen receptor 1 | 0 | 2 | 0 | 2 |
| estrogen receptor beta isoform 1 | 0 | 3 | 0 | 3 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 2 | 0 | 2 |
| Insulin receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 3 | 1 | 4 |
| Neutral alpha-glucosidase AB | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, Proto-oncogene Tyrosine-protein Kinase Src | 0 | 1 | 0 | 1 |
| Chain A, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
| Chain B, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
| Chain A, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
| Chain B, N5-carboxyaminoimidazole ribonucleotide mutase | 0 | 0 | 1 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| 3-dehydroquinate dehydratase | 0 | 0 | 1 | 1 |
| ATP-citrate synthase | 0 | 0 | 0 | 1 |
| Ribonuclease T | 0 | 0 | 0 | 1 |
| Cell death-related nuclease 4 | 0 | 0 | 0 | 1 |
| 3-dehydroquinate dehydratase | 0 | 0 | 1 | 1 |
| Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
| Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
| N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 2 | 0 | 3 |
| General amino-acid permease GAP1 | 0 | 0 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 0 | 3 | 3 |
| Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
| Alpha-1A adrenergic receptor | 0 | 5 | 3 | 8 |
| D(3) dopamine receptor | 0 | 14 | 0 | 14 |
| Amine oxidase [flavin-containing] A | 0 | 12 | 0 | 12 |
| D(1B) dopamine receptor | 0 | 8 | 0 | 8 |
| Amine oxidase [flavin-containing] B | 0 | 6 | 1 | 7 |
| Alpha-2B adrenergic receptor | 0 | 2 | 0 | 4 |
| D(4) dopamine receptor | 0 | 8 | 0 | 8 |
| Alpha-2C adrenergic receptor | 0 | 2 | 0 | 4 |
| Alpha-2A adrenergic receptor | 0 | 2 | 0 | 4 |
| Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
| Nischarin | 0 | 2 | 0 | 2 |
| Nischarin | 0 | 3 | 0 | 3 |
| Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
| Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
| Chain H, Fab M82G2, Heavy chain | 0 | 0 | 1 | 1 |
| Chain L, Fab M82G2, Light chain | 0 | 0 | 1 | 1 |
| Chain H, Fab M82g2, Heavy Chain | 0 | 0 | 1 | 1 |
| Chain L, Fab M82g2, Light Chain | 0 | 0 | 1 | 1 |
| Fatty acid-binding protein, heart | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 1 | 2 |
| Tryptophan 5-hydroxylase 1 | 0 | 2 | 0 | 2 |
| Liver carboxylesterase 1 | 0 | 1 | 0 | 6 |
| Lysosomal Pro-X carboxypeptidase | 0 | 2 | 0 | 2 |
| Sodium-dependent dopamine transporter | 0 | 3 | 0 | 3 |
| Leukotriene B4 receptor 2 | 0 | 2 | 1 | 4 |
| Cytochrome P450 2D1 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2D26 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2D3 | 0 | 2 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 6 | 1 | 10 |
| Mu-type opioid receptor | 0 | 7 | 1 | 12 |
| Cytochrome P450 2D4 | 0 | 2 | 0 | 2 |
| Mas-related G-protein coupled receptor member X2 | 0 | 0 | 4 | 4 |
| nuclear receptor subfamily 0 group B member 1 | 0 | 2 | 0 | 2 |
| steroidogenic factor 1 | 0 | 2 | 0 | 2 |
| Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 1 | 1 | 2 |
| Adenylate cyclase type 2 | 0 | 1 | 1 | 2 |
| Adenylate cyclase type 8 | 0 | 0 | 1 | 1 |
| Relaxin receptor 1 | 0 | 0 | 1 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 4 | 4 |
| Sex hormone-binding globulin | 0 | 0 | 2 | 2 |
| Corticosteroid-binding globulin | 0 | 3 | 0 | 3 |
| Neuromedin-K receptor | 0 | 0 | 3 | 3 |
| Neuromedin-K receptor | 0 | 4 | 3 | 7 |
| Neuromedin-K receptor | 0 | 1 | 1 | 2 |
| Substance-K receptor | 0 | 4 | 0 | 4 |
| Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
| Proton-coupled amino acid transporter 1 | 0 | 8 | 0 | 8 |
| ATP-binding cassette sub-family C member 9 | 0 | 0 | 2 | 2 |
| ATP-binding cassette sub-family C member 8 | 0 | 1 | 2 | 3 |
| ATP-sensitive inward rectifier potassium channel 11 | 0 | 1 | 2 | 3 |
| ATP-sensitive inward rectifier potassium channel 8 | 0 | 0 | 1 | 1 |
| G protein-coupled receptor GPR35 | 0 | 0 | 2 | 2 |
| G-protein coupled receptor 35 | 0 | 0 | 1 | 1 |
| Multidrug resistance-associated protein 5 | 0 | 2 | 0 | 3 |
| Chain A, N-methyl-D-aspartate Receptor Subunit 1 | 0 | 1 | 0 | 1 |
| Chain A, N-methyl-D-aspartate Receptor Subunit 1 | 0 | 1 | 0 | 1 |
| Chain A, N-methyl-D-aspartate Receptor Subunit 1 | 0 | 1 | 0 | 1 |
| D-alanine--D-alanine ligase | 0 | 1 | 0 | 1 |
| UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase | 0 | 1 | 0 | 1 |
| chaperonin GroEL | 2 | 0 | 0 | 2 |
| Sodium-dependent noradrenaline transporter | 0 | 2 | 0 | 2 |
| Glycogen phosphorylase, brain form | 0 | 1 | 0 | 1 |
| Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2C | 0 | 3 | 0 | 3 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
| Histone-lysine N-methyltransferase SETD7 | 0 | 2 | 0 | 2 |
| Glutathione S-transferase P | 0 | 1 | 0 | 1 |
| Alpha-tocopherol transfer protein | 0 | 0 | 1 | 1 |
| Beta-glucuronidase | 0 | 2 | 0 | 2 |
| Beta-glucuronidase | 0 | 1 | 0 | 1 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 6 | 0 | 6 |
| G-protein coupled bile acid receptor 1 | 0 | 1 | 2 | 3 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| NPC1-like intracellular cholesterol transporter 1 | 0 | 0 | 1 | 1 |
| Albumin | 0 | 12 | 13 | 26 |
| Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | 0 | 2 | 0 | 2 |
| Protein farnesyltransferase subunit beta | 0 | 2 | 0 | 2 |
| Sodium-dependent neutral amino acid transporter B(0)AT2 | 0 | 3 | 0 | 3 |
| Hsf1 protein | 0 | 0 | 3 | 3 |
| Gamma-aminobutyric acid | 0 | 2 | 1 | 3 |
| Alpha-1-acid glycoprotein 1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 2 | 1 | 3 |
| Translocator protein | 0 | 1 | 0 | 1 |
| Translocator protein | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 2 | 1 | 3 |
| Sphingosine-1-phosphate lyase 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 2 | 1 | 3 |
| Nicotinamide phosphoribosyltransferase | 0 | 0 | 1 | 1 |
| Acetylcholine-binding protein | 0 | 2 | 1 | 3 |
| Soluble acetylcholine receptor | 0 | 2 | 0 | 2 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B10 | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 1 | 5 | 7 |
| Dihydrofolate reductase | 0 | 6 | 0 | 7 |
| Interleukin-8 | 0 | 3 | 0 | 3 |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha | 0 | 1 | 0 | 1 |
| Fatty acid-binding protein, intestinal | 0 | 5 | 0 | 5 |
| Aldo-keto reductase family 1 member B1 | 0 | 4 | 0 | 4 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 8 | 0 | 8 |
| C-X-C chemokine receptor type 1 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 8 | 0 | 8 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 8 | 0 | 8 |
| Sodium- and chloride-dependent betaine transporter | 0 | 8 | 0 | 8 |
| UDP-glucuronosyltransferase 1A7 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A10 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 2 | 0 | 2 |
| STAT3, partial | 0 | 1 | 0 | 1 |
| signal transducer and activator of transcription 1-alpha/beta isoform alpha | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 2 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 2 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 2 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit gamma | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
| runt-related transcription factor 1 isoform AML1b | 2 | 0 | 0 | 2 |
| core-binding factor subunit beta isoform 2 | 2 | 0 | 0 | 2 |
| Caspase-7 | 6 | 0 | 0 | 6 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 4 | 2 | 6 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 4 | 1 | 5 |
| Prostaglandin F2-alpha receptor | 0 | 2 | 0 | 2 |
| Prostaglandin F2-alpha receptor | 0 | 3 | 2 | 5 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 4 | 2 | 6 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 4 | 1 | 5 |
| Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
| Prostaglandin D2 receptor | 0 | 3 | 1 | 4 |
| Solute carrier family 22 member 7 | 0 | 1 | 0 | 6 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 4 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Histamine N-methyltransferase | 0 | 0 | 0 | 1 |
| Calcium release-activated calcium channel protein 1 | 0 | 1 | 0 | 1 |
| Protein orai-2 | 0 | 1 | 0 | 1 |
| Protein orai-3 | 0 | 1 | 0 | 1 |
| eyes absent homolog 2 isoform a | 3 | 0 | 0 | 3 |
| Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
| 90-kda heat shock protein beta HSP90 beta, partial | 0 | 2 | 0 | 2 |
| DNA polymerase III, partial | 4 | 0 | 0 | 4 |
| isocitrate dehydrogenase 1, partial | 6 | 0 | 0 | 6 |
| LANA | 0 | 0 | 0 | 1 |
| kelch-like ECH-associated protein 1 | 0 | 0 | 0 | 2 |
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | 0 | 1 | 0 | 1 |
| 3',5'-cyclic-AMP phosphodiesterase | 0 | 5 | 0 | 5 |
| Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha | 0 | 1 | 0 | 1 |
| Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
| Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta | 0 | 1 | 0 | 1 |
| Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0 | 1 | 0 | 1 |
| Exopolyphosphatase PRUNE1 | 0 | 1 | 0 | 1 |
| Single-stranded DNA cytosine deaminase | 3 | 0 | 0 | 3 |
| Phosphodiesterase | 0 | 3 | 0 | 3 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 2 | 0 | 2 |
| glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 2 | 0 | 2 |
| polypyrimidine tract-binding protein 1 isoform a | 1 | 0 | 0 | 1 |
| bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase | 0 | 1 | 0 | 1 |
| pyruvate kinase PKM isoform b | 5 | 0 | 0 | 5 |
| Carbamate kinase | 0 | 1 | 0 | 1 |
| Retinal dehydrogenase 1 | 0 | 1 | 0 | 1 |
| Aldehyde dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| Ornithine decarboxylase | 5 | 0 | 0 | 5 |
| C-X-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
| Mitogen-activated protein kinase 3 | 0 | 2 | 0 | 2 |
| Protein-lysine 6-oxidase | 0 | 1 | 0 | 1 |
| C-C chemokine receptor type 5 | 0 | 4 | 0 | 4 |
| Gasdermin-D | 0 | 1 | 0 | 1 |
| Lysyl oxidase homolog 3 | 0 | 1 | 0 | 1 |
| NACHT, LRR and PYD domains-containing protein 3 | 0 | 2 | 0 | 2 |
| Lysyl oxidase homolog 4 | 0 | 1 | 0 | 1 |
| Histone-lysine N-methyltransferase EHMT2 | 0 | 1 | 0 | 1 |
| Monoglyceride lipase | 0 | 2 | 0 | 2 |
| Gasdermin-D | 0 | 1 | 0 | 1 |
| Histone-lysine N-methyltransferase EHMT1 | 0 | 1 | 0 | 1 |
| Lysyl oxidase homolog 2 | 0 | 1 | 0 | 1 |
| hypothetical protein CAALFM_CR05890CA | 0 | 0 | 0 | 1 |
| H3 histone acetyltransferase | 0 | 0 | 0 | 1 |
| large T antigen | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase Chk1 | 0 | 1 | 0 | 1 |
| N-arachidonyl glycine receptor | 0 | 1 | 1 | 2 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 1 | 2 | 3 |
| Lysophosphatidylserine lipase ABHD12 | 0 | 1 | 0 | 1 |
| Monoacylglycerol lipase ABHD6 | 0 | 1 | 0 | 1 |
| G-protein coupled receptor 55 | 0 | 1 | 2 | 3 |
| N-acetyltransferase Eis | 0 | 3 | 0 | 3 |
| Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2b | 0 | 0 | 0 | 2 |
| Adenylate cyclase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1B | 0 | 6 | 1 | 7 |
| Motilin receptor | 0 | 0 | 1 | 1 |
| low molecular weight phosphotyrosine protein phosphatase isoform c | 0 | 1 | 0 | 1 |
| Motilin receptor | 0 | 1 | 1 | 2 |
| Chitinase B | 0 | 1 | 0 | 1 |
| Low molecular weight phosphotyrosine protein phosphatase | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit alpha | 0 | 3 | 1 | 4 |
| Acetylcholine receptor subunit beta | 0 | 3 | 1 | 4 |
| Acetylcholine receptor subunit gamma | 0 | 3 | 1 | 4 |
| Acetylcholine receptor subunit delta | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit delta | 0 | 3 | 1 | 4 |
| Acetylcholine receptor subunit alpha | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit gamma | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit beta | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
| LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 2 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 2 | 0 | 2 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 2 | 0 | 2 |
| nuclear receptor coactivator 3 isoform a | 0 | 2 | 0 | 2 |
| Regulatory protein E2 | 0 | 0 | 2 | 2 |
| DNA topoisomerase 1 | 0 | 4 | 2 | 8 |
| DNA topoisomerase 2 | 0 | 0 | 0 | 1 |
| Caspase-3 | 0 | 4 | 0 | 4 |
| DNA topoisomerase 2-alpha | 0 | 0 | 0 | 1 |
| DNA topoisomerase 2-beta | 0 | 2 | 1 | 9 |
| Tubulin beta-2B chain | 0 | 3 | 1 | 6 |
| Integrase | 0 | 4 | 0 | 4 |
| Similar to alpha-tubulin isoform 1 | 0 | 3 | 1 | 6 |
| Similar to alpha-tubulin isoform 1 | 0 | 3 | 0 | 5 |
| Luciferin 4-monooxygenase | 0 | 1 | 0 | 1 |
| Nuclear factor NF-kappa-B p105 subunit | 0 | 1 | 0 | 2 |
| Tyrosine-protein phosphatase 1 | 0 | 1 | 0 | 1 |
| Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | 0 | 2 | 0 | 2 |
| Vesicular glutamate transporter 3 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C3 | 0 | 7 | 0 | 7 |
| Aldo-keto reductase family 1 member C2 | 0 | 5 | 0 | 5 |
| NAD-dependent protein deacetylase sirtuin-2 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-1 | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 8 | 4 | 13 |
| DNA gyrase subunit B | 0 | 2 | 0 | 2 |
| DNA gyrase subunit A | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 1 | 0 | 3 |
| Voltage-dependent T-type calcium channel subunit alpha-1G | 0 | 0 | 1 | 1 |
| Voltage-dependent T-type calcium channel subunit alpha-1H | 0 | 0 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit beta-1 | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
| Voltage-dependent T-type calcium channel subunit alpha-1I | 0 | 0 | 1 | 1 |
| Prostaglandin D2 receptor 2 | 0 | 3 | 1 | 4 |
| Acid-sensing ion channel 3 | 0 | 2 | 0 | 2 |
| Aldo-keto reductase family 1 member C4 | 0 | 4 | 0 | 4 |
| Acid-sensing ion channel 1 | 0 | 2 | 0 | 2 |
| Aldo-keto reductase family 1 member C1 | 0 | 4 | 0 | 4 |
| Cysteinyl leukotriene receptor 1 | 0 | 7 | 0 | 9 |
| Cysteinyl leukotriene receptor 2 | 0 | 9 | 3 | 12 |
| Cysteinyl leukotriene receptor 1 | 0 | 13 | 5 | 18 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 2 | 1 | 3 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 5 | 0 | 5 |
| Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
| Sodium/bile acid cotransporter | 0 | 4 | 0 | 4 |
| CDGSH iron-sulfur domain-containing protein 1 | 0 | 4 | 0 | 4 |
| fructose-bisphosphate aldolase A | 1 | 0 | 0 | 1 |
| Pancreatic triacylglycerol lipase | 0 | 4 | 0 | 4 |
| Urokinase-type plasminogen activator | 0 | 3 | 0 | 3 |
| Tissue-type plasminogen activator | 0 | 1 | 0 | 1 |
| Plasminogen activator inhibitor 1 | 0 | 1 | 0 | 1 |
| Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
| Matrilysin | 0 | 1 | 0 | 1 |
| L-selectin | 0 | 1 | 0 | 1 |
| P-selectin | 0 | 1 | 0 | 1 |
| E-selectin | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 2 | 0 | 2 |
| Proteasome subunit beta type-5 | 0 | 1 | 0 | 1 |
| 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 | 0 | 1 | 0 | 1 |
| Squalene monooxygenase | 0 | 1 | 0 | 1 |
| Autoinducer 2-binding periplasmic protein LuxP | 0 | 1 | 0 | 1 |
| Anthrax toxin receptor 2 | 0 | 2 | 0 | 2 |
| Lactoperoxidase | 0 | 2 | 0 | 3 |
| Polypeptide N-acetylgalactosaminyltransferase 2 | 0 | 1 | 1 | 2 |
| Alpha-(1,3)-fucosyltransferase 7 | 0 | 1 | 0 | 1 |
| CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 | 0 | 1 | 0 | 1 |
| Toll-like receptor 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent taurine transporter | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| 4-aminobutyrate aminotransferase, mitochondrial | 0 | 0 | 0 | 1 |
| Sterol O-acyltransferase 1 | 0 | 0 | 1 | 1 |
| Platelet glycoprotein VI | 0 | 1 | 2 | 4 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Chain A, Glutamine Binding Protein | 0 | 0 | 1 | 1 |
| Neutral amino acid transporter A | 0 | 3 | 0 | 3 |
| Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Neutral amino acid transporter B(0) | 0 | 3 | 0 | 3 |
| Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 3 |
| Amino acid transporter | 0 | 3 | 0 | 3 |
| Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 2 | 0 | 2 |
| Serine racemase | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
| Pancreatic alpha-amylase | 0 | 1 | 0 | 1 |
| Beta-glucuronidase | 0 | 2 | 0 | 2 |
| High mobility group protein B1 | 0 | 0 | 3 | 3 |
| High mobility group protein B1 | 0 | 0 | 0 | 1 |
| Corticosteroid 11-beta-dehydrogenase isozyme 2 | 0 | 1 | 1 | 2 |
| Chain A, 3-phosphoshikimate 1-carboxyvinyltransferase | 0 | 1 | 0 | 1 |
| Chain A, 3-phosphoshikimate 1-carboxyvinyltransferase | 0 | 1 | 0 | 1 |
| Glutamine synthetase | 0 | 1 | 0 | 1 |
| Cytochrome P450 71B1 | 0 | 1 | 0 | 2 |
| Glutamine synthetase | 0 | 1 | 0 | 1 |
| 2-dehydro-3-deoxyphosphooctonate aldolase | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 1 | 0 | 1 | 0 | 1 |
| Cocaine esterase | 0 | 2 | 0 | 2 |
| Vitamin D-binding protein | 0 | 1 | 0 | 1 |
| Integrin beta-1 | 0 | 1 | 0 | 1 |
| Integrin alpha-4 | 0 | 1 | 0 | 1 |
| Carbonyl reductase [NADPH] 1 | 0 | 0 | 0 | 1 |
| D(2) dopamine receptor | 0 | 3 | 0 | 3 |
| Adenylate cyclase type 3 | 0 | 1 | 0 | 1 |
| Beta-3 adrenergic receptor | 0 | 4 | 1 | 5 |
| Adenylate cyclase type 4 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 8 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
| AP-2 complex subunit sigma | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 6 | 0 | 1 | 0 | 1 |
| Calcitonin gene-related peptide type 1 receptor | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 2 | 0 | 2 |
| Zinc finger protein 664 | 0 | 1 | 0 | 1 |
| Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
| Transporter | 0 | 1 | 0 | 1 |
| Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
| Adenylyl cyclase 7 | 0 | 1 | 0 | 1 |
| D | 0 | 1 | 0 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
| Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
| Plasma kallikrein | 0 | 0 | 0 | 2 |
| Macrophage migration inhibitory factor | 0 | 5 | 0 | 5 |
| Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
| Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
| Histamine H4 receptor | 0 | 1 | 2 | 3 |
| Histamine H4 receptor | 0 | 1 | 2 | 3 |
| Histamine H4 receptor | 0 | 1 | 0 | 1 |
| Chain A, HISTIDINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
| Histidine-binding periplasmic protein | 0 | 0 | 1 | 1 |
| N-glycosylase/DNA lyase | 0 | 2 | 0 | 2 |
| Aspartate aminotransferase, cytoplasmic | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 2 | 0 | 2 |
| Cyclic GMP-AMP synthase | 0 | 1 | 0 | 1 |
| Toll-like receptor 9 | 0 | 1 | 0 | 1 |
| Toll-like receptor 7 | 0 | 1 | 0 | 1 |
| Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 4 | 0 | 4 |
| Ribonucleoside-diphosphate reductase large subunit | 0 | 1 | 0 | 1 |
| Caspase-4 | 0 | 3 | 0 | 3 |
| Caspase-5 | 0 | 3 | 0 | 3 |
| Caspase-9 | 0 | 3 | 0 | 3 |
| Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 0 | 3 | 4 |
| Mitogen-activated protein kinase 1 | 0 | 4 | 0 | 4 |
| Cytosolic phospholipase A2 | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 0 | 3 | 4 |
| Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
| Envelope glycoprotein | 0 | 0 | 1 | 1 |
| Chain A, membrane-associated prostaglandin E synthase-2 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 6 | 0 | 6 |
| Phospholipase A2, major isoenzyme | 0 | 1 | 0 | 2 |
| Androgen receptor | 0 | 3 | 1 | 4 |
| Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
| Multidrug resistance-associated protein 1 | 0 | 5 | 1 | 8 |
| C-X-C chemokine receptor type 3 | 0 | 5 | 0 | 5 |
| Prostaglandin D2 receptor | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 2 | 0 | 5 |
| Lactoylglutathione lyase | 0 | 4 | 0 | 4 |
| Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
| Chain A, ADENOSINE DEAMINASE | 0 | 1 | 0 | 1 |
| Chain A, ADENOSINE DEAMINASE | 0 | 1 | 0 | 1 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 3 | 0 | 0 | 3 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 4 | 1 | 6 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 4 | 2 | 6 |
| Acetylcholinesterase | 0 | 0 | 1 | 1 |
| Lysosomal protective protein | 0 | 1 | 0 | 1 |
| Fatty acid synthase | 0 | 1 | 0 | 1 |
| Liver carboxylesterase | 0 | 1 | 0 | 1 |
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
| Formamidopyrimidine-DNA glycosylase | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 2 | 0 | 2 |
| DNA gyrase subunit B | 0 | 2 | 0 | 2 |
| Endonuclease III-like protein 1 | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 3 | 0 | 3 |
| DNA gyrase subunit A | 0 | 3 | 0 | 3 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 2 | 0 | 4 |
| Pantothenate synthetase | 0 | 1 | 0 | 1 |
| Isocitrate lyase | 0 | 1 | 0 | 1 |
| Putative FAD-containing monooxygenase MymA | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Endonuclease 8-like 1 | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 1 | 2 |
| Beta-adrenergic receptor kinase 1 | 0 | 0 | 3 | 3 |
| Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
| Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
| Taste receptor type 2 member 38 | 0 | 0 | 1 | 2 |
| Taste receptor type 2 member 39 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 40 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 41 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 43 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 31 | 0 | 0 | 3 | 3 |
| Taste receptor type 2 member 45 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 46 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 30 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 19 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 20 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 50 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 60 | 0 | 0 | 2 | 2 |
| Oxytocin receptor | 0 | 1 | 1 | 2 |
| Taste receptor type 2 member 42 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 16 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 14 | 0 | 0 | 2 | 2 |
| Taste receptor type 2 member 13 | 0 | 0 | 2 | 2 |
| Taste receptor type 2 member 10 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 9 | 0 | 0 | 2 | 2 |
| Taste receptor type 2 member 8 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 7 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 5 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 4 | 0 | 0 | 2 | 2 |
| Taste receptor type 2 member 3 | 0 | 0 | 1 | 1 |
| Taste receptor type 2 member 1 | 0 | 0 | 1 | 1 |
| Ornithine decarboxylase | 0 | 0 | 0 | 1 |
| Retinoic acid receptor alpha | 0 | 1 | 0 | 1 |
| Retinoic acid receptor gamma | 0 | 1 | 0 | 1 |
| Retinoic acid receptor beta | 0 | 1 | 0 | 1 |
| Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
| Retinoic acid receptor RXR-alpha | 0 | 1 | 0 | 1 |
| Retinoic acid receptor RXR-beta | 0 | 1 | 0 | 1 |
| Retinoic acid receptor RXR-gamma | 0 | 1 | 0 | 1 |
| Cellular retinoic acid-binding protein 1 | 0 | 1 | 0 | 1 |
| Cellular retinoic acid-binding protein 1 | 0 | 0 | 1 | 1 |
| Chymotrypsinogen A | 0 | 4 | 0 | 4 |
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
| Gap junction alpha-1 protein | 0 | 1 | 0 | 1 |
| Gap junction beta-2 protein | 0 | 1 | 0 | 1 |
| Acyl-protein thioesterase 1 | 0 | 1 | 0 | 1 |
| Prostaglandin E synthase 2 | 0 | 1 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 1 | 1 | 2 |
| Chain A, Lectin | 0 | 0 | 1 | 1 |
| Chain A, Lectin | 0 | 0 | 1 | 1 |
| Chain A, Lectin | 0 | 0 | 1 | 1 |
| Chain A, Lectin | 0 | 0 | 1 | 1 |
| Chain A, ERYTHRINA CRISTA-GALLI LECTIN | 0 | 0 | 1 | 1 |
| Chain A, ERYTHRINA CRISTA-GALLI LECTIN | 0 | 0 | 1 | 1 |
| Chain A, cellulase | 0 | 0 | 1 | 1 |
| Chain A, cellulase | 0 | 0 | 1 | 1 |
| Chain A, Galectin-3 | 0 | 0 | 1 | 1 |
| Chain A, Anti-tumor lectin | 0 | 1 | 0 | 1 |
| Galectin-3 | 0 | 1 | 0 | 1 |
| Galectin-9 | 0 | 0 | 1 | 1 |
| Galectin-8 | 0 | 0 | 1 | 1 |
| Beta-galactoside-binding lectin | 0 | 1 | 0 | 1 |
| Galectin-1 | 0 | 1 | 1 | 3 |
| Galectin-3 | 0 | 1 | 1 | 2 |
| Galectin-3 | 0 | 1 | 1 | 3 |
| Galectin-7 | 0 | 0 | 1 | 1 |
| Alpha 1,4 galactosyltransferase | 0 | 0 | 0 | 1 |
| P2Y purinoceptor 12 | 0 | 1 | 1 | 2 |
| Alkaline phosphatase, placental type | 0 | 1 | 0 | 1 |
| Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
| Intestinal-type alkaline phosphatase | 0 | 2 | 0 | 2 |
| Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
| 5'-nucleotidase | 0 | 1 | 0 | 1 |
| Phospholipase A-2-activating protein | 0 | 2 | 0 | 2 |
| Neurotensin receptor type 2 | 0 | 1 | 1 | 2 |
| Potassium voltage-gated channel subfamily A member 5 | 0 | 3 | 0 | 3 |
| Potassium voltage-gated channel subfamily D member 2 | 0 | 2 | 0 | 2 |
| Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
| Bile acid receptor | 0 | 2 | 1 | 3 |
| Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
| Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
| Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
| Platelet-activating factor acetylhydrolase | 0 | 3 | 0 | 3 |
| Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
| D | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
| histone-lysine N-methyltransferase NSD2 isoform 1 | 0 | 0 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 3 | 1 | 4 |
| Methionine aminopeptidase | 0 | 1 | 0 | 1 |
| Vascular endothelial growth factor receptor 2 | 0 | 2 | 0 | 2 |
| Calmodulin-domain protein kinase 1 | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit alpha | 0 | 2 | 2 | 4 |
| Acetylcholine receptor subunit gamma | 0 | 2 | 2 | 4 |
| Acetylcholine receptor subunit beta | 0 | 2 | 2 | 4 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 3 | 1 | 5 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 3 | 1 | 4 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 3 | 1 | 5 |
| Acetylcholine receptor subunit epsilon | 0 | 0 | 2 | 2 |
| Acetylcholine receptor subunit delta | 0 | 2 | 2 | 4 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Transcription factor SOX-18 | 0 | 1 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
| Multidrug transporter MdfA | 0 | 2 | 0 | 2 |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor DM1 | 0 | 4 | 0 | 4 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Toll-like receptor 4 | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 2 | 4 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Folate receptor beta | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Folate receptor alpha | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Histidine decarboxylase | 0 | 1 | 3 | 4 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 2 | 0 | 0 | 1 | 1 |
| Bifunctional purine biosynthesis protein ATIC | 0 | 3 | 0 | 3 |
| Reduced folate transporter | 0 | 2 | 0 | 2 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| Pteridine reductase 1 | 0 | 1 | 0 | 1 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
| Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
| Multidrug resistance associated protein | 0 | 1 | 0 | 2 |
| Beta-secretase 1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A13 | 0 | 3 | 3 | 6 |
| Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
| T cell receptor, partial | 1 | 0 | 0 | 1 |
| luteinizing hormone receptor | 1 | 0 | 0 | 1 |
| integrase, partial | 0 | 1 | 0 | 1 |
| lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
| Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
| Apoptotic peptidase activating factor 1 | 0 | 1 | 0 | 1 |
| luciferase | 1 | 0 | 0 | 1 |
| neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
| caspase-9 isoform alpha precursor | 0 | 1 | 0 | 1 |
| caspase-3 isoform a preproprotein | 0 | 1 | 0 | 1 |
| replicative DNA helicase | 0 | 0 | 0 | 1 |
| recombinase A | 0 | 0 | 1 | 1 |
| Glutathione reductase | 0 | 1 | 0 | 1 |
| Glycoprotein hormones alpha chain | 2 | 0 | 0 | 2 |
| Dihydrolipoyl dehydrogenase, mitochondrial | 0 | 1 | 0 | 2 |
| Microtubule-associated protein tau | 0 | 1 | 1 | 2 |
| Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 2 |
| Dihydrolipoyl dehydrogenase | 0 | 1 | 0 | 2 |
| phosphoglycerate kinase | 3 | 0 | 0 | 3 |
| G-protein coupled receptor | 0 | 1 | 0 | 1 |
| Leukotriene C4 synthase | 0 | 1 | 0 | 1 |
| Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
| Opioid receptor homologue | 0 | 1 | 0 | 1 |
| Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
| Proteinase-activated receptor 1 | 0 | 2 | 1 | 3 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| D-amino-acid oxidase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
| Formyl peptide receptor-related sequence 1 | 0 | 0 | 1 | 1 |
| fMet-Leu-Phe receptor | 0 | 3 | 2 | 5 |
| N-formyl peptide receptor 2 | 0 | 0 | 2 | 2 |
| FML2_HUMAN | 0 | 0 | 1 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 1 |
| Pyruvate kinase PKM | 0 | 1 | 1 | 2 |
| DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
| DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 2 |
| Hormone-sensitive lipase | 0 | 1 | 0 | 1 |
| Substance-K receptor | 0 | 1 | 2 | 3 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| Neuropeptide Y receptor type 1 | 0 | 2 | 0 | 2 |
| Neuropeptide Y receptor type 2 | 0 | 2 | 0 | 2 |
| Neutrophil elastase | 0 | 2 | 0 | 2 |
| Equilibrative nucleoside transporter 1 | 0 | 1 | 0 | 1 |
| B2 bradykinin receptor | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Acetylcholine receptor subunit beta-like 2 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 1 | 2 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 1 | 2 |
| Neuronal acetylcholine receptor subunit alpha-5 | 0 | 2 | 0 | 2 |
| Liver carboxylesterase B-1 | 0 | 1 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-3 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-4 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
| Neuronal acetylcholine receptor subunit beta-2 | 0 | 2 | 1 | 3 |
| Neuronal acetylcholine receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
| Integrin beta | 0 | 0 | 1 | 1 |
| Glycoprotein IIb | 0 | 0 | 1 | 1 |
| Phospholipase A2, membrane associated | 0 | 0 | 0 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
| Myosin light chain kinase, smooth muscle | 0 | 1 | 0 | 1 |
| Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| Interstitial collagenase | 0 | 2 | 0 | 2 |
| Sodium/iodide cotransporter | 0 | 1 | 0 | 1 |
| Lysine-specific demethylase 4C | 0 | 2 | 0 | 2 |
| Tubulin beta 8B | 0 | 0 | 1 | 1 |
| Tubulin beta-4A chain | 0 | 2 | 4 | 8 |
| Tubulin beta chain | 0 | 2 | 4 | 8 |
| Tubulin alpha-3C chain | 0 | 2 | 4 | 8 |
| Tubulin alpha-1B chain | 0 | 2 | 4 | 8 |
| Tubulin alpha-4A chain | 0 | 2 | 4 | 8 |
| Tubulin beta-4B chain | 0 | 2 | 4 | 8 |
| Tubulin beta-3 chain | 0 | 3 | 4 | 9 |
| Tubulin beta-2A chain | 0 | 2 | 4 | 8 |
| Tubulin beta-8 chain | 0 | 2 | 4 | 8 |
| Tubulin alpha-3E chain | 0 | 2 | 4 | 8 |
| Tubulin alpha-1A chain | 0 | 2 | 4 | 8 |
| Tubulin alpha-1C chain | 0 | 2 | 4 | 8 |
| Tubulin beta-6 chain | 0 | 2 | 4 | 8 |
| Tubulin beta-2B chain | 0 | 2 | 4 | 8 |
| Tubulin beta-1 chain | 0 | 2 | 4 | 8 |
| N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 0 | 0 | 1 |
| Nitric oxide synthase, brain | 0 | 1 | 0 | 1 |
| Neuraminidase | 0 | 4 | 0 | 4 |
| Neuraminidase | 0 | 6 | 0 | 6 |
| Neuraminidase | 0 | 4 | 0 | 4 |
| Neuraminidase | 0 | 3 | 0 | 3 |
| Neuraminidase | 0 | 2 | 0 | 2 |
| Neuraminidase | 0 | 4 | 0 | 4 |
| Sialidase | 0 | 2 | 0 | 2 |
| Acyl-CoA desaturase 1 | 0 | 2 | 0 | 2 |
| Neuraminidase | 0 | 4 | 0 | 4 |
| Neuraminidase | 0 | 4 | 0 | 4 |
| Neuraminidase | 0 | 2 | 0 | 2 |
| Neuraminidase | 0 | 2 | 0 | 2 |
| Sialidase-4 | 0 | 3 | 0 | 3 |
| Sialidase-1 | 0 | 2 | 0 | 2 |
| Sialidase-3 | 0 | 3 | 0 | 3 |
| Sialidase-2 | 0 | 3 | 0 | 3 |
| L-lactate dehydrogenase C chain | 0 | 1 | 0 | 1 |
| Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase A chain | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase B chain | 0 | 2 | 0 | 2 |
| Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase B chain | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase A chain | 0 | 1 | 0 | 1 |
| Bcl-2-like protein 1 | 0 | 2 | 0 | 2 |
| L-lactate dehydrogenase | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase B chain | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase | 0 | 1 | 0 | 1 |
| L-lactate dehydrogenase | 0 | 1 | 0 | 1 |
| voltage-dependent T-type calcium channel subunit alpha-1H isoform a | 0 | 0 | 1 | 1 |
| P2X purinoceptor 7 | 0 | 1 | 0 | 1 |
| MCOLN3 protein | 0 | 0 | 1 | 1 |
| transient receptor potential cation channel, subfamily N, member 1 | 0 | 0 | 1 | 1 |
| Mineralocorticoid receptor | 0 | 0 | 1 | 1 |
| Alpha-1B adrenergic receptor | 0 | 3 | 0 | 3 |
| Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
| Valosin-containing protein | 0 | 1 | 0 | 1 |
| Vasopressin V1b receptor | 0 | 1 | 0 | 1 |
| Vasopressin V2 receptor | 0 | 1 | 0 | 1 |
| Tubulin alpha-1A chain | 0 | 2 | 2 | 5 |
| Tubulin beta chain | 0 | 2 | 2 | 4 |
| Integrin alpha-V | 0 | 2 | 0 | 2 |
| Apoptosis regulator Bcl-2 | 0 | 1 | 0 | 1 |
| Cholecystokinin receptor type A | 0 | 3 | 1 | 4 |
| Tyrosine-protein kinase Mer | 0 | 1 | 0 | 1 |
| Beta-tubulin | 0 | 1 | 0 | 1 |
| Nucleotide-binding oligomerization domain-containing protein 2 | 0 | 1 | 0 | 1 |
| Chain A, cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 1 |
| Vascular endothelial growth factor receptor 1 | 0 | 1 | 0 | 1 |
| Serine hydroxymethyltransferase, mitochondrial | 0 | 1 | 0 | 1 |
| Vascular endothelial growth factor receptor 3 | 0 | 1 | 0 | 1 |
| CREB-binding protein | 1 | 0 | 0 | 1 |
| cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 2 | 0 | 2 |
| Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
| Cystathionine gamma-lyase | 0 | 2 | 0 | 2 |
| Gastrin/cholecystokinin type B receptor | 0 | 1 | 1 | 2 |
| Protein arginine N-methyltransferase 5 | 0 | 1 | 0 | 1 |
| Protein tyrosine phosphatase type IVA 3 | 0 | 1 | 0 | 1 |
| Coagulation factor X | 0 | 1 | 0 | 1 |
| Plasminogen | 0 | 3 | 1 | 4 |
| Protein S100-B | 0 | 1 | 1 | 2 |
| Protein S100-B | 0 | 0 | 1 | 1 |
| Acrosin | 0 | 1 | 0 | 1 |
| Amiloride-sensitive amine oxidase [copper-containing] | 0 | 1 | 0 | 1 |
| Diamine acetyltransferase 1 | 0 | 1 | 0 | 1 |
| Protein tyrosine phosphatase type IVA 2 | 0 | 1 | 0 | 1 |
| Protein tyrosine phosphatase type IVA 1 | 0 | 1 | 0 | 1 |
| Protein arginine N-methyltransferase 1 | 0 | 2 | 0 | 2 |
| Suppressor of tumorigenicity 14 protein | 0 | 1 | 0 | 1 |
| Tumor necrosis factor | 0 | 2 | 1 | 3 |
| Chitotriosidase-1 | 0 | 3 | 1 | 4 |
| Endochitinase B1 | 0 | 3 | 1 | 4 |
| Cytochrome P450 11B1, mitochondrial | 0 | 2 | 0 | 2 |
| Chain A, Immunoglobulin | 0 | 0 | 1 | 1 |
| Chain B, Immunoglobulin | 0 | 0 | 1 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M5 | 0 | 1 | 1 | 3 |
| rac GTPase-activating protein 1 isoform a | 0 | 2 | 0 | 2 |
| Serine/threonine-protein kinase D3 | 0 | 1 | 0 | 2 |
| Protein kinase C gamma type | 0 | 1 | 0 | 2 |
| Protein kinase C beta type | 0 | 2 | 0 | 3 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
| Protein kinase C alpha type | 0 | 1 | 0 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX12 | 0 | 2 | 0 | 2 |
| Protein kinase C eta type | 0 | 1 | 0 | 2 |
| Protein kinase C iota type | 0 | 1 | 0 | 2 |
| Protein kinase C epsilon type | 0 | 2 | 0 | 3 |
| Protein kinase C theta type | 0 | 1 | 0 | 2 |
| Protein kinase C zeta type | 0 | 1 | 0 | 2 |
| Protein kinase C delta type | 0 | 1 | 0 | 2 |
| Serine/threonine-protein kinase D1 | 0 | 1 | 0 | 2 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
| Chain A, Lysozyme | 0 | 0 | 1 | 1 |
| Chain A, Lysozyme | 0 | 0 | 1 | 1 |
| Chain A, Lysozyme | 0 | 0 | 1 | 1 |
| Chain A, Lysozyme | 0 | 0 | 1 | 1 |
| Chain A, Ferritin light chain | 0 | 0 | 2 | 2 |
| Chain A, Ferritin light chain | 0 | 0 | 2 | 2 |
| Chain A, Ferritin light chain | 0 | 0 | 2 | 2 |
| Chain A, Ferritin light chain | 0 | 0 | 2 | 2 |
| Chain A, Ferritin light chain | 0 | 0 | 2 | 2 |
| Chain A, Ferritin light chain | 0 | 0 | 2 | 2 |
| Chain A, Ferritin light chain | 0 | 0 | 2 | 2 |
| Endolysin | 0 | 0 | 2 | 2 |
| NADPH oxidase 1 | 0 | 2 | 0 | 2 |
| Trace amine-associated receptor 5 | 0 | 0 | 1 | 1 |
| fMet-Leu-Phe receptor | 0 | 2 | 0 | 2 |
| POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 3 |
| Chain A, Hth-type Transcriptional Regulator Ttgr | 0 | 0 | 1 | 1 |
| Chain A, Hth-type Transcriptional Regulator Ttgr | 0 | 0 | 1 | 1 |
| fibroblast growth factor 22 isoform 1 precursor | 0 | 0 | 0 | 2 |
| serine/threonine-protein kinase 33 isoform a | 0 | 0 | 1 | 1 |
| Estrogen receptor | 0 | 6 | 1 | 8 |
| Beta-lactamase | 0 | 2 | 0 | 2 |
| Sodium/glucose cotransporter 1 | 0 | 2 | 0 | 2 |
| Sodium/glucose cotransporter 2 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 1 | 0 | 1 | 0 | 1 |
| Nuclear factor NF-kappa-B p100 subunit | 0 | 1 | 0 | 1 |
| Transcription factor p65 | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 2 | 0 | 1 | 0 | 1 |
| Sodium/hydrogen exchanger 9B2 | 0 | 1 | 0 | 1 |
| Regulatory protein E2 | 0 | 0 | 1 | 1 |
| Regulatory protein E2 | 0 | 0 | 1 | 1 |
| Calcium-activated potassium channel subunit alpha-1 | 0 | 1 | 0 | 1 |
| Sodium/potassium/calcium exchanger 4 | 0 | 1 | 1 | 2 |
| Sodium/potassium/calcium exchanger 2 | 0 | 1 | 1 | 2 |
| Renin | 0 | 1 | 0 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| Progesterone receptor | 0 | 4 | 0 | 5 |
| Glucocorticoid receptor | 0 | 2 | 1 | 3 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Mineralocorticoid receptor | 0 | 3 | 2 | 5 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 5 | 1 | 6 |
| Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 2 |
| Voltage-dependent calcium channel subunit alpha-2/delta-2 | 0 | 1 | 0 | 1 |
| Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| DNA (cytosine-5)-methyltransferase 1 | 0 | 1 | 0 | 1 |
| Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
| DNA (cytosine-5)-methyltransferase 3-like | 0 | 1 | 0 | 1 |
| DNA (cytosine-5)-methyltransferase 3A | 0 | 1 | 0 | 1 |
| Glutamate 5-kinase | 0 | 0 | 0 | 1 |
| Calmodulin-1 | 0 | 1 | 1 | 2 |
| Free fatty acid receptor 3 | 0 | 0 | 1 | 1 |
| Free fatty acid receptor 2 | 0 | 1 | 1 | 2 |
| Free fatty acid receptor 2 | 0 | 0 | 1 | 1 |
| Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
| Interleukin-5 | 0 | 1 | 0 | 1 |
| Interleukin-5 | 0 | 1 | 0 | 1 |
| Interleukin-5 receptor subunit alpha | 0 | 1 | 0 | 1 |
| Pyridoxal kinase | 0 | 0 | 0 | 1 |
| Histidine-rich protein PFHRP-II | 0 | 1 | 0 | 1 |
| Multidrug resistance protein 1a | 0 | 0 | 0 | 1 |
| Chromaffin granule amine transporter | 0 | 1 | 0 | 1 |
| Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
| Synaptic vesicular amine transporter | 0 | 2 | 1 | 3 |
| Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
| NS5 | 0 | 0 | 1 | 1 |
| Polymerase basic protein 2 | 0 | 0 | 1 | 1 |
| RNA-directed RNA polymerase catalytic subunit | 0 | 0 | 1 | 1 |
| Polymerase acidic protein | 0 | 1 | 2 | 3 |
| Genome polyprotein | 0 | 0 | 1 | 1 |
| DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
| NH(3)-dependent NAD(+) synthetase | 0 | 1 | 0 | 1 |
| Arylacetamide deacetylase | 0 | 1 | 0 | 2 |
| Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
| DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
| inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Cytochrome c oxidase subunit 1 | 0 | 1 | 0 | 1 |
| Transporter | 0 | 1 | 0 | 1 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Retina-specific copper amine oxidase | 0 | 1 | 0 | 1 |
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B | 0 | 1 | 0 | 1 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 2 | 0 | 2 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Protein cereblon | 0 | 2 | 0 | 2 |
| Platelet-activating factor receptor | 0 | 3 | 0 | 3 |
| Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 1 | 1 |
| Prolyl endopeptidase | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 10 | 0 | 1 | 0 | 1 |
| Dihydroorotate dehydrogenase | 0 | 1 | 0 | 1 |
| Neuromedin-U receptor 2 | 0 | 0 | 1 | 1 |
| RmtA | 0 | 1 | 0 | 1 |
| Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
| Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
| Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
| Chain A, 146aa long hypothetical transcriptional regulator | 0 | 0 | 1 | 1 |
| Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain B, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain C, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 1 | 0 | 2 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
| Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 1 | 0 | 2 |
| Xanthine dehydrogenase/oxidase | 0 | 2 | 0 | 3 |
| Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 2 | 0 | 2 |
| Type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
| Amine oxidase [flavin-containing] A | 0 | 0 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 0 | 0 | 1 |
| Substance-K receptor | 0 | 1 | 0 | 1 |
| Orexin receptor type 1 | 0 | 0 | 0 | 1 |
| Cathepsin B | 0 | 1 | 0 | 1 |
| Growth hormone secretagogue receptor type 1 | 0 | 0 | 1 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Aurora kinase A | 0 | 1 | 0 | 1 |
| nonstructural protein 1 | 0 | 1 | 0 | 1 |
| Chain A, Glutathione S-transferase | 0 | 1 | 0 | 1 |
| Fibroblast growth factor 1 | 0 | 0 | 1 | 1 |
| Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
| Cystine/glutamate transporter | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 12 | 0 | 1 | 0 | 1 |
| Chain A, CES1 protein | 0 | 1 | 0 | 1 |
| Protein kinase C alpha type | 0 | 2 | 0 | 2 |
| Protein kinase C delta type | 0 | 2 | 0 | 2 |
| Protein kinase C epsilon type | 0 | 2 | 0 | 2 |
| Protein kinase C zeta type | 0 | 2 | 0 | 2 |
| Steroid hormone receptor ERR1 | 0 | 1 | 0 | 1 |
| Transcriptional activator protein LuxR | 0 | 2 | 0 | 2 |
| Estrogen-related receptor gamma | 0 | 1 | 0 | 1 |
| Protein kinase C gamma type | 0 | 2 | 0 | 2 |
| Protein kinase C beta type | 0 | 2 | 0 | 2 |
| Phospholipase D1 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
| Phospholipase D1 | 0 | 1 | 0 | 1 |
| Protein kinase C eta type | 0 | 2 | 0 | 2 |
| Emopamil-binding protein-like | 0 | 2 | 0 | 2 |
| 7-dehydrocholesterol reductase | 0 | 1 | 1 | 2 |
| Protein kinase C theta type | 0 | 2 | 0 | 2 |
| cGMP-gated cation channel alpha-1 | 0 | 0 | 1 | 1 |
| Tetracycline resistance protein, class B | 0 | 0 | 0 | 1 |
| Neutrophil collagenase | 0 | 1 | 0 | 1 |
| Chain A, Pyridoxal kinase | 0 | 1 | 0 | 1 |
| Chain A, Pyridoxal Kinase | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 1 | 0 | 1 |
| Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 0 | 1 | 1 |
| Chain A, ykoF | 0 | 0 | 1 | 1 |
| Chain B, ykoF | 0 | 0 | 1 | 1 |
| Chain A, ThiT | 0 | 0 | 1 | 1 |
| Thiamine transporter ThiT | 0 | 0 | 1 | 1 |
| Transketolase | 0 | 0 | 1 | 1 |
| Thiamine-binding periplasmic protein | 0 | 0 | 1 | 1 |
| Urease subunit alpha | 0 | 1 | 0 | 1 |
| Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase ATR | 0 | 1 | 0 | 1 |
| Chain A, ODORANT-BINDING PROTEIN | 0 | 1 | 0 | 1 |
| Chain A, ODORANT-BINDING PROTEIN | 0 | 1 | 0 | 1 |
| Chain B, Odorant-binding Protein | 0 | 1 | 0 | 1 |
| Chain A, ODORANT-BINDING PROTEIN | 0 | 1 | 0 | 1 |
| Chain A, ODORANT-BINDING PROTEIN | 0 | 1 | 0 | 1 |
| Chain A, ODORANT-BINDING PROTEIN | 0 | 1 | 0 | 1 |
| Secreted chorismate mutase | 0 | 2 | 0 | 2 |
| Heat sensitive channel TRPV3 | 0 | 0 | 1 | 1 |
| Transient receptor potential cation channel subfamily M member 8 | 0 | 1 | 1 | 2 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
| Proliferating cell nuclear antigen | 0 | 1 | 0 | 1 |
| Retinoic acid receptor RXR-alpha | 0 | 0 | 2 | 2 |
| Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
| Protein Rev | 0 | 0 | 1 | 1 |
| Trace amine-associated receptor 1 | 0 | 1 | 0 | 1 |
| tyrosine-protein kinase Yes | 2 | 0 | 0 | 2 |
| DNA topoisomerase 1 | 0 | 1 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha | 0 | 1 | 1 | 2 |
| Endothelial PAS domain-containing protein 1 | 0 | 0 | 1 | 1 |
| Chain A, PLASMINOGEN | 0 | 0 | 1 | 1 |
| Chain A, PLASMINOGEN | 0 | 0 | 1 | 1 |
| MSH | 0 | 0 | 0 | 1 |
| Hematopoietic prostaglandin D synthase | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
| procathepsin L isoform 1 preproprotein | 0 | 1 | 0 | 1 |
| Ubiquitin carboxyl-terminal hydrolase 1 | 0 | 1 | 0 | 1 |
| Lysozyme C-1 | 0 | 1 | 0 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
| DNA-dependent protein kinase catalytic subunit | 0 | 2 | 0 | 2 |
| Calcium-dependent protein kinase 4 | 0 | 1 | 0 | 1 |
| WD repeat-containing protein 48 | 0 | 1 | 0 | 1 |
| Chain A, CARBONIC ANHYDRASE II | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B7 | 0 | 1 | 0 | 1 |
| D-alanyl-D-alanine dipeptidase | 0 | 1 | 0 | 1 |
| Alpha-glucosidase MAL12 | 0 | 1 | 0 | 1 |
| Enoyl-acyl-carrier protein reductase | 0 | 1 | 0 | 1 |
| Transcription intermediary factor 1-alpha | 0 | 1 | 0 | 1 |
| E3 ubiquitin-protein ligase TRIM33 | 0 | 1 | 0 | 1 |
| Glycoprotein | 0 | 1 | 0 | 1 |
| Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
| Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
| Ricin | 0 | 1 | 0 | 1 |
| M-phase inducer phosphatase 1 | 0 | 1 | 0 | 1 |
| Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
| Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
| Chain A, Neuraminidase | 0 | 1 | 0 | 1 |
| Chain A, Neuraminidase | 0 | 1 | 0 | 1 |
| Chain A, Neuraminidase | 0 | 1 | 0 | 1 |
| Chain A, Neuraminidase | 0 | 1 | 0 | 1 |
| Chain A, Neuraminidase | 0 | 1 | 0 | 1 |
| Chain A, Neuraminidase | 0 | 1 | 0 | 1 |
| Chain A, NEURAMINIDASE | 0 | 1 | 0 | 1 |
| Chain A, Neuraminidase | 0 | 1 | 0 | 1 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| Sialidase-1 | 0 | 1 | 0 | 1 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| Neuraminidase | 0 | 1 | 1 | 2 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| Sialidase A | 0 | 1 | 0 | 1 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| Chain A, Phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| Ectonucleoside triphosphate diphosphohydrolase 1 | 0 | 0 | 0 | 1 |
| Thymidine kinase, cytosolic | 0 | 2 | 0 | 3 |
| DNA polymerase beta | 0 | 1 | 0 | 1 |
| Thymidine kinase, cytosolic | 0 | 0 | 0 | 1 |
| Thymidylate kinase | 0 | 1 | 0 | 1 |
| Thymidine kinase | 0 | 1 | 0 | 2 |
| Thymidine kinase | 0 | 1 | 0 | 2 |
| Tumor necrosis factor ligand superfamily member 11 | 0 | 1 | 0 | 1 |
| Acyl-CoA:cholesterol acyltransferase | 0 | 1 | 0 | 1 |
| twin arginine protein translocation system - TatA protein | 0 | 0 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |